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Summary
Laparoscopic cholecystectomy was first performed by Mouret in France in 
1987. Although laparoscopic cholecystectomy has rapidly been introduced 
into routine practice, there has been no rigorous evaluation comparing it with 
open cholecystectomy. Use of a small transverse subcostal incision 
("minilaparotomy") for open cholecystectomy has been shown to result in a 
more rapid postoperative recovery than standard incisions 1-7 Therefore a 
trial was undertaken in which some 300 patients were randomised to 
laparoscopic (151) or minilaparotomy (148) cholecystectomy over an eighteen 
months period.
Over the first year of the trial, postoperative pain, opiate analgesia 
consumption, oxygen saturation and pulmonary function (forced vital 
capacity (FVC), forced expiratory volume in one second(FEVl), and peak 
expiratory flow rate (PEFR)) were assessed after laparoscopic (n=67) and 
minilaparotomy (n=65) cholecystectomy. Laparoscopic cholecystectomy was 
associated with lower linear analogue pain scores (median 40 v 59 mm, 
p<0 .001), lower patient-controlled morphine consumption (median 22  versus 
40 mg, p<0.001), a smaller reduction in postoperative pulmonary function 
(mean PEFR 64% of pre-operative value versus 49%, p<0.001) and better 
oxygen saturation (mean 92.9% versus 91.2%, p=0.008) than minilaparotomy 
cholecystectomy.
In the randomised trial as a whole, recovery after surgery was assessed by 
length of hospital stay, outpatient review at ten days and four weeks, and a 
modified version of of the SF-36 health survey questionnaire one, four and 
twelve weeks after surgery. The median operation time was 20 minutes 
shorter for minilaparotomy (50 versus 70 minutes, p<0.001), while the median 
postoperative hospital stay was shorter after laparoscopic cholecystectomy (2
versus 4 days, jxO.OOl). The mean hospital cost was £396 greater for the 
laparoscopic procedure (£1486 versus £1090, p<0.001). There was a similar 
incidence of complications after both procedures (minilaparotomy group 2 0 %, 
laparoscopic group 17%).
Laparoscopic patients returned to work in the home more rapidly (median 10 
versus 15 days, p<0.001). At one week, laparoscopic patients had 
significantly better physical and social functioning, less role limitation due to 
physical problems, less pain, and lower depression scores. At four weeks, only 
the physical functioning and depression scores were better in the laparoscopic 
group, and by three months, there were no significant differences. 
Laparoscopic patients were more satisfied with the overall outcome of their 
operation, and the appearance of their scars. Compared with minilaparotomy 
cholecystectomy, laparoscopic cholecystectomy results in moderate benefits 
in length of hospital stay, post-operative dysfunction, and time to return to 
normal activity, but an increased cost to the National Health Service.
The stress of surgery evokes a wide variety of biochemical and physiological 
changes, known as the metabolic response to injury. The magnitude of the 
metabolic response to injury has been shown to be proportional to the degree 
of the surgical trauma 8-U. As part of the randomised trial, the metabolic 
response to laparoscopic (n=10) and minilaparotomy cholecystectomy (n=10) 
was assessed. Venous blood samples were taken at 0 ,3 ,6 ,9 , 12 ,18 ,24 ,48 ,72  
and 168 hours after incision and analysed for C reactive protein, interleukin-6 , 
cortisol, albumin, transferrin, iron, fibrinogen, fibrin degradation products, 
polymorphonuclear elastase, neutrophil, and lymphocyte count. 24h urine 
samples were analysed for urea, creatinine, 3-methylhistidine and 
catecholamines. The magnitude of the metabolic changes from base-line levels 
was quantified by calculating areas under each individual curve. A significant
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metabolic response with a similar time course and magnitude of changes 
occurred after laparoscopic and minilaparotomy cholecystectomy but with 
wide inter-individual variation in the magnitude of the response. The 
laparoscopic technique did not reduce the metabolic response when 
compared with open surgery using a small incision.
Some recent studies have suggested that during laparoscopic 
cholecystectomy carbon dioxide absorption from the pneumoperitoneum may 
result in hypercarbia and respiratory acidosis 12-14. in order to clarify these 
previous findings, ventilatory and arterial blood gas changes were assessed 
during laparoscopic (n=30) and minilaparotomy (n=30) cholecystectomy as 
part of the randomised trial. Measurements were made during anaesthesia 
before commencing surgery, and at the time of removal of the gallbladder. 
Despite an increase in minute ventilation from a mean (SD) of 5.7 (1.4) litres to
6.1 (1.2) litres (95% Cl of the difference 0.01-0.9), arterial carbon dioxide 
tension (P^coi) rose from 5.3 (0 .6) to 6.0 (0.9) kPa (95% Cl of the difference 
0.3-0.9) during laparoscopic cholecystectomy. Peak airway pressure 
increased from 17 (4) to 23 (4) cm H2O (95% Cl of the difference 5-7). By 
comparison, no clinically significant changes in ventilation or blood gas values 
occurred during minilaparotomy cholecystectomy. Laparoscopic 
cholecystectomy using a CO2 pneumoperitoneum is associated with a 
significant increase in carbon dioxide output, requiring a significant but 
variable increase in minute ventilation to prevent hypercarbia.
End-tidal CO2 partial pressure (P^coi) monitoring is increasingly used during 
anaesthesia as an indirect measure of arterial CO2 tension (Paco2)- Therefore 
the relationship between these two variables was assessed. P e ' c o 2 had poor 
precision in predicting Paco2 (95% limits of agreement -0.61 to +1.93 kPa). 
The mean (Paco2 - ^e'cc>2) did not change significantly during surgery,
23
although there was significant within-patient variation. During laparoscopic 
cholecystectomy, minute ventilation should be be increased to maintain P e 'c o 2 
towards the lower end of the normal range (4-5 kPa) in order to avoid 
inadvertent hypercarbia.
In some patients with severe cardiac or respiratory disease undergoing 
laparoscopic cholecystectomy, it may be impossible to eliminate the increased 
CO2 burden by hyperventilation 13,15, Therefore, a study was carried out to 
assess helium as an alternative to carbon dioxide for creating the 
pneumoperitoneum. Ventilation requirements, Paco2and Peco2 were 
assessed before creating the pneumoperitoneum and at the time of gallbladder 
removal during laparoscopic cholecystectomy using a helium 
pneumoperitoneum (n=30). Helium pneumoperitoneum did not result in any 
significant changes in minute ventilation requirement, although like CO2 
pneumoperitoneum, it was associated with a mean rise in peak airway pressure 
of 7 cm H2O (pcO.OOl, paired t test). There was a 3.2 kPa rise in the alveolar- 
arterial oxygen gradient (p=0.006). Four patients had surgical emphysema 
persisting for five days. Helium may be a suitable alternative for patients with 
severe cardiorespiratory disease undergoing laparoscopic procedures in whom 
carbon dioxide insufflation results in excessive hypercarbia and acidosis.
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LI History of Cholecystectomy
The first cholecystectomy was performed in Germany by Carl Langenbuch on 
July 15th, 1882 16-18. in spite of the fact that the operation was successful, he 
engendered much criticism among his peers 19. Nevertheless, before the turn 
of the century, cholecystectomy had become a common operation 20. 
Cholecystectomy has now been the gold standard treatment for gallstone 
disease for over 100 years, despite the development of a whole range of 
different treatment options. It is currently the most frequently performed 
elective major operation in the western world. Over 600,000 
cholecystectomies are performed each year in the USA 21 and up to 50,000 in 
the UK and Ireland 22
1.2 Gallstones, Symptoms, and Indications for Treatment
Cholelithiasis is common, but the majority of subjects with stones are and 
remain asymptomatic. In a cross-sectional screening study in Denmark 
involving a sample of 4,807 subjects, the prevalence of gallstones in 30 year 
old females was 5% increasing to 22% in 60 year olds, whereas in males the 
incidence was 2% and 13% respectively 2^. However, of those subjects with 
gallstones, only a third had had right upper quadrant pain and less than 10% 
had had right upper quadrant pain radiating to the shoulder 24.
There is general agreement on what constitutes symptomatic gallstone disease, 
namely the occurrence of biliary pain, acute cholecystitis, biliary obstruction 
or pancreatitis 2^. Upper abdominal pain not clearly due to another cause in 
the presence of gallstones is often ascribed to gallstones. Nevertheless, even 
patients with apparently typical biliary pain may not be relieved of their 
symptoms by cholecystectomy 25-28? suggesting a significant degree of 
diagnostic inaccuracy. With the reduced morbidity and patient discomfort 
with the new methods of cholecystectomy, has come a reduced symptom
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threshold for cholecystectomy, if not in this country, certainly in the United 
States 2930  and Germany 3132. in the University of Cologne group’s first 400 
laparoscopic cholecystectomies, 14 per cent were asymptomatic and 56 per 
cent had only mild and very occasional symptoms not requiring analgesia, 
whereas before the introduction of laparoscopic cholecystectomy, these two 
categories together comprised only 10 per cent of their cholecystectomy 
patients 32. Words of caution have been made against the non-discriminating 
application of laparoscopic cholecystectomy to patients with vague 
complaints. Spiro satirically referred to such operations as "diagnostic 
laparoscopic cholecystectomies" - "lap-choly will not cure the pains of life" 33.
1.3 Sequelae of Cholecystectomy
Biliary symptoms may be replaced after cholecystectomy by new symptoms in 
part due to gallbladder removal. Loss of the reservoir function of the 
gallbladder results in disturbance of bile changes from intermittent, meal- 
related to continuous, and its composition also changes, becoming more 
damaging to gastric and oesophageal mucosa. This leads to increased 
duodenogastric reflux 34, which is aggravated further by the impaired 
function of the antropyloric motor unit that appears to result from a direct 
effect of bile on the duodenum 35. Subsequent symptoms have been related 
to the increased incidence of gastritis (described in up to 50 per cent of 
patients), to alkaline duodenogastric reflux 34, and to the qualitative change in 
bile composition 36. Gastro-oesophageal reflux and the incidence of 
oesophagitis also increases after cholecystectomy 3738. The bile salt pool is 
reduced by 50 per cent, which may result in subclinical fat malabsorption and 
post-cholecystectomy diarrhoea which may be attributed to bile catharsis 39. 
Finally, some authors have claimed that cholecystectomy results in an 
increased risk of colorectal cancer 40. Although there is a definite association
between gallstones and colorectal cancer 41, it remains unclear whether 
cholecystectomy per se is an independent risk factor.
It is because cholecystectomy has several adverse longterm sequelae, that 
some have advocated using treatments that preserved the gallbladder in 
patients in whom it is still functioning 22
1.4 Gallbladder preserving treatments for gallstones 
Oral dissolution therapy
Oral dissolution therapy, which was first used in 1970 42, has considerable 
limitations. Less than 20% of patients are suitable for treatment (criteria are 
non-pigment, radiolucent stones less than 1cm in diameter in a fuctioning 
gallbladder in a non-obese patient) 43. With treatment taking up to 2 years for 
complete stone dissolution, treatment is expensive 44 Even in selected 
patients, it will completely dissolve stones in only 40-60% of patients 44, with 
recurrence at 5 years of 50% 45.
Extracorporeal shockwave lithotripsy
This treatment method was first applied to gallstones in humans in 1986 46. 
Absolute inclusion criterion for this treatment is a functioning gallbladder. 
Additional inclusion criteria laid down in the Munich study 47, are radiolucent 
stones which are less than 3 cm in diameter, and not more than three, which 
leaves only 15% of patients suitable for lithotripsy 48. Using these entry 
criteria, 90% of patients treated by lithotripsy (with adjuvant litholytic 
therapy) are gallstone free after 12-18 months. However, a recent 
randomised trial found that compared to open cholecystectomy, lithotripsy 
was only cost-effective for patients with a stone bulk less than 4 cubic 
centimetres 49
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Percutaneous cholecystolithotomy
Percutaneous cholecystolithotomy, is a minimally invasive technique allowing 
surgical removal of stones while preserving the gallbladder 50,51# The only 
exclusion criterion is a contracted thickwalled gallbladder. It is performed 
under general anaethesia or local anaesthesia with intravenous sedation and 
takes 25-90 minutes. At the end of the procedure, a Foley catheter is left in 
the gallbladder which is removed after 10 days. The procedure is successful in 
90% of cases. Patients are discharged 24-48 h after the procedure, returning 
for removal of a Foley catheter. However, open cholecystolithotomy is 
associated with an 83% symptomatic stone recurrence rate at 15 years 52, and 
therefore it is likely that this technique will only be suitable for elderly patients 
unfit for cholecystectomy.
Since gallbladder preserving treatments for cholelithiasis are only applicable to 
a small percentage of patients, for the foreseeable future cholecystectomy is 
likely to remain the treatment of choice for symptomatic gallstones in the 
majority of patients. Langenbuch's assertion that "the gallbladder needs to be 
removed not because it contains stones but because it forms them" is a 
pertinent today as it was over 100 years ago 16_ 18 .
1.5 Methods of performing cholecystectomy
The first cholecystectomy was performed through a T-shaped laparotomy 
incision 16-18 The horizontal limb of the incision was parallel to the liver 
edge and the longitudinal limb ran along the lateral border of the rectus 
muscle. Nowadays, the most commonly used incisions are right paramedian, 
midline, oblique subcostal (Kocher's), and transverse subcostal incision. The 
transverse or oblique subcostal incisions are preferred by most surgeons 
because they result in less postoperative pain and less reduction in 
postoperative pulmonary function than midline incisions 53,54 The Kocher's
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incision extends from the tip of the ziphoid caudally and laterally 5-6 cm 
below the costal margin into the flank 55. Such an incision varies in length 
between 15 and 30 cm depending upon the size of the patient, and is 
recommended for adequate exposure with minimal retraction.
1.6 Minilaparotomy cholecystectomy
It is likely that many surgeons over the years have used small incisions for 
performing open cholecystectomy. However the first published report of 
minilaparotomy cholecystectomy was by Dubois in 1982 1. He used a 
transverse incision 3 to 6  cm long in a series of 1500 cholecystectomies out of 
a total of 1800 cholecystectomies over a 10 year period. Further reports over 
the last decade were made by Goco 2*56, Morton 57, Merrill 3, O'Dwyer 5, 
O'Kelly 6, and Moss 58*59. In essence, the technique is simply an open 
cholecystectomy limited to an incision of 4-6 cm, but the surgeons's hand does 
not enter the abdomen at any stage. A number of aids to the procedure have 
been described. The use of a headlight may be helpful to provide additional 
lighting through the incision which resembles a well 5. Russell and Shankar 
recommended the use of a stabilized ring retractor with a variety of fixed and 
malleable blades to provide accurate, fixed retraction 60. In elderly patients, 
the rectus muscle may be split along its fibres 5 or retracted medially 61, 
although in younger patients this does not usually provide adequate 
exposure. A fundus first dissection technique is often easier in 
minilaparotomy cholecystectomy. The minilaparotomy cholecystectomy 
technique is undoubtedly technically demanding, and many surgeons find the 
restricted access difficult. Obesity, which is common in this patient group, 
makes the procedure even more difficult, and often the incision requires to be 
extended 5.
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1.7 Laparoscopic cholecystectomy
Diagnostic laparoscopy was first performed in a dog by Kelling using a 
cystoscope in 190162, and in humans by Jacobeus in 1911 63. In the 1930s, a 
spring-loaded needle designed by Veress for therapeutic pneumothorax, was 
modified for the safe introduction of gas into the abdomen. Gynaecologists in 
Europe began to use laparoscopy regularly for diagnosis and tubal diathermy 
in the 1960s. Semm developed instruments and techniques for gynaecological 
procedures and in 1983 performed the first laparoscopic appendicectomy 64.
Laparoscopic cholecystectomy was first performed in March 1987 by Philipe 
Mouret, a French surgeon, with experience in gynaecological laparoscopic / 
procedures 65. After hearing about the method, Dubois began performing the 
technique in May 1988, reporting the results of his first 36 procedures a year 
later 66,67. Perissat was also a key figure in the early development of the 
technique in France 68-70 Word of the technique spread rapidly. Reddick 
and Olsen introduced the technique to the United States, performing their first 
case in September 1988 71, and comparing its outcome with minilaparotomy 72. 
The technical development which allowed the procedure to become 
widespread was the small video camera, allowing the operation to be viewed 
on a televison screen. By 1990, it was estimated that over 2500 procedures 
had been performed world-wide 73, and by September 1991, there had been 
more than 14 reported series totalling 3225 operations 74.
The rapid development and introduction of laparoscopic cholecystectomy 
into routine practice as the preferred technique of cholecystectomy is 
unprecedented in the history of surgical procedures. Laparoscopic 
cholecystectomy was introduced into routine practice before full evaluation, 
and certainly before any controlled data were available. The rush to adopt the 
technique was driven firstly by equipment manufacturers and health care
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providers through advertisements and promotions, and secondly by 
consumers who had been convinced, by media coverage, that the method had 
significant proven advantages 75. The enthusiasm for the laparoscopic 
technique has spread to encompass the whole of surgical gastroenterology, 
with many surgeons attempting virtually every conceivable abdominal 
operation by the laparoscopic technique.
1.8 Comparison of laparoscopic and open cholecystectomy
Many of the reported series on laparoscopic cholecystectomy are difficult to 
compare to those on open cholecystectomy because patients in laparoscopic 
series are a selected subgroup of patients. They are younger, have less severe 
biliary disease than those requiring emergency surgery, and patients with 
possible common bile duct stones are often excluded. Operations are usually 
performed by surgeons performing large numbers of cases 32,76,77 unlike open 
cholecystectomy, in which many operations are performed by surgeons 
performing fewer cases or surgeons in training 78_80. In addition, the 
accuracy of the data from large, multi-centre reports 77,81 has been 
questioned 82_84. Also, it is a well recognised fact that publication bias occurs 
in the reporting of a new procedure with serious complications and bad results 
less likely to be reported 85.
1.9 Bile duct injury
Bile duct injury during cholecystectomy is undoubtedly a catastrophic event 
that can lead to significant long-term morbidity (recurrent stricture, cholangitis, 
reoperation, cirrhosis, and premature death)86. It is difficult to calculate 
accurately the incidence of bile duct injuries after open or laparoscopic 
cholecystectomy for three reasons: firstly because it is an uncommon problem, 
secondly beacuse of under-reporting and thirdly, because of variations in the 
precise definition of what constitutes a bile duct injury. A small longitudinal
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tear, which is immediately repaired by primary suture or insertion of a T tube 
has a quite different prognosis from complete division of the bile ducts above 
the bifurcation, which goes unrecognised, and is repaired at a delayed interval.
The incidence of bile duct injury in reported series of open cholecystectomy is 
shown in Table 1.1 78,79,87-97 The average incidence was only 0.2%. The 
series reported by Roslyn et al. 94 was a retrospective audit using information 
from computerized discharge data from all hospitals in California and 
Maryland in 1989. The 91 patients in this series with possible bile duct injury 
(0 .21 %) included patients with laceration of the gastrointestinal tract or a 
biliary fistula, and the authors therefore concluded that this was likely to be an 
overestimate of the true bile duct injury rate. Only one of the eight other bile 
duct injuries reported in the series shown in Table 1.1 required biliary 
reconstruction; the remaining seven were managed by T tube insertion (two), 
peritoneal drainage (three), suture of the laceration (one), and stricture 
dilatation (one). Although, intuitively, it might be thought that 
minilaparotomy cholecystectomy might result in more bile duct injuries 
because of the restricted access, in the published results for over 2500 cases 
1-7,57,60,86,98-100 there have been only two bile duct injuries, one requiring 
hepaticojejunostomy 98, and the other, a 2mm longitudinal laceration of the 
common bile duct, requiring only T tube insertion 6.
Several early reports 32>10l, some some of which were anecdotal 102-105^  
found that laparoscopic cholecystectomy was associated with an increased 
bile duct injury rate compared to open cholecystectomy. In a series of 400 
operations 32, Troidl et al. reported 4 bile duct injuries (1%), one of which 
resulted in death. Traverso reported 17 common bile duct injuries (2.8%) in a 
series of 597 operations 104. In a series of 264 laparoscopic 
cholecystectomies performed in 10 hospitals in the south-east of England,
Author Period Number Bile Duct Injuries
of series (ref.) (years) of patients n (%)
Vanderpool 87 1976-85 360 0 0 .00
Ganey 88 1978-83 1,035 0 0 .00
Warwick 89 1982-90 384 0 0 .00
Clavien 90 1984-89 1,088 0 0 .00
Davies 91 1985-90 630 0 0 .00
Saltzstein 92 1988-90 500 0 0 .00
Herzog 93 1984-90 1357 1 0.07
Morgensten 78 1982-88 980 2 0 .20
Cox 94 1985-89 457 1 0.21
Roslyn 95 1989 42,474 91 0.21
Raute 96 1972-91 7057 16 0 .22
Harte 97 1973-78 390 1 0.26
Gilliland 79 1982-87 671 3 0.45
TO TA L 57,383 115 0.20
TABLE 1.1 Bile duct injury rate in reported series of open 
cholecystectomy.
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there were 5 bile duct injuries (1.9%), 4 of which required 
hepaticojejunostomy 103.
Lord Smith of Marlow reported his findings from interviewing biliary surgeons 
attending the American College of Surgeons in 1991 102. All surgeons 
interviewed reported that bile duct injuries from laparoscopic 
cholecystectomy were occurring out of all proportion to that encountered at 
open cholecystectomy. From the first 4 surgeons interviewed, Lord Smith 
"gleaned" more than 30 bile duct injuries. He went on to comment that for the 
non-specialist occasional cholecystectomist "laparoscopic cholecystectomy 
was a recipe for disaster - a keyhole scar and catastrophy within". These 
increased risks of laparoscopic cholcystectomy have received coveraged in 
the national press 106. Specialist hepatobiliary units on both sides of the 
Atlantic have reported a dramatic increase in the number of referrals for the 
management of bile duct injuries 103,107-112
Most single centre series of more than 300 laparoscopic cholecystectomies 
have reported a bile duct injury rate less than 0.4%, with an average of 0.26% 
96,113-128  ^although two series reported a incidence of 1% or more 32,129 
(Table 1.2). By contrast, nine out of sixteen multicentre audit series found a 
bile duct injury rate greater than 0.4%, with an average of 0.5% 
29,76,77,81,130-137 (Table 1.3). Two factors may explain this apparent 
discrepancy. Firstly, it is a well recognised fact that publication bias occurs in 
the reporting of a new procedure with serious complications and bad results 
less likely to be reported 85. Secondly, the single centre series are reported by 
surgeons who have performed large numbers of procedures, and are therefore 
far up the "learning curve", whereas the majority of surgeons in audit series are 
probably still on the "learning curve".
A uthor 
(ref. no.)
n Bile duct injuries 
n %
Ko 113 300 0 0 .00
Nottle 1^4 308 0 0 .00
Fitzgibbons 165 350 0 0 .00
Wilson 117 350 0 0 .00
Wolfe H 8 381 0 0 .00
Taniguchi 128 600 0 0 .00
Lane 123 641 0 0 .00
Baird 125 800 0 0 .00
Graffis 126 900 0 0 .00
Raute 96 1,022 0 0 .00
Barkun 166 1,300 5 0.38
Soper 124 647 1 0.15
Clair 121 514 1 0.19
Brown 120 474 1 0.21
Berci H 9 418 1 0.24
Davis 122 622 2 0.32
McGee 127 950 3 0.32
Graves H 4 304 1 0.33
Perissat 167 700 3 0.43
Troidl 32 400 4 1.00
Kozarek 129 597 11 1.84
TOTAL 12,578 33 0.26
TABLE 1.2 Bile duct injury rate in reported series of
laparoscopic cholecystectomy with more than 
300 patients.
A uthor Place Number Bile Duct In jury
of patients n %
Litwin 130 Canada 2,201 3 0.14
Airan 131 USA 2,671 5 0.19
Larson 76 USA 1,983 5 0.25
Deveny 132 Oregon state 9,597 27 0.28
Dunn 133 England 2,131 6 0.28
Orlando 29 Connecticut State 4,640 15 0.32
Cuschieri 77 Europe 1,236 4 0.32
Ref. 133 Switzerland 1,091 5 0.46
Meyer 81 USA 1,518 7 0.46
Deziel 134 USA 77,604 365 0.47
G igot136 Belgium 3,244 16 0.49
Fullarton 135 Scotland 1,655 11 0 .66
Sue 136 France 3,606 25 0.69
Go 137 Netherlands 6,076 52 0 .86
Ref. 133 Japan 2,888 26 0.90
Ref. 133 Singapore 1,100 10 0.91
TOTAL 123,241 582 0.47
TABLE 1.3 Bile duct injury rate in multicentre audit series 
laparoscopic cholecystectomy with more than 
1,000 patients.
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There is substantial evidence to suggest that the learning curve has 
contributed to the high rates of bile duct injury. In the Southern Surgeons 
Club series, the bile duct injury rate in the first 13 patients operated on by 
each surgical group was 2 .2%, as compared with 0 .1% for subsequent 
patients 81. In the national survey of United States hospitals 134, the average 
bile duct injury rate was 0.65% in hospitals with less than 100 laparoscopic 
cholecystectomies performed compared with 0.42% at hospitals with more 
than 100 performed. Similarly, in the Connecticut state audit29, half of the 
bile duct injuries had occurred in the surgeon's first 10 cases, a third in the 
surgeon's 11th to 50th case, and only an eighth of injuries occurred after the 
50th case. Of 17 biliary injuries or leaks reported by Kozarek 129, 13 occurred 
within the first 20  procedures performed by the surgeon.
Learning curve aside, it is still generally acknowledged that the common bile 
duct is more at risk during laparoscopic cholecystectomy than open 
cholecystectomy 107-110. This is because cephalad traction on the fundus 
compresses Calot's triangle while lateral traction on Hartmann’s pouch tents 
up the common bile duct, which is then mistaken for the cystic duct, especially 
when the cystic duct is very short. The classic pattern of laparoscopic injury 
is resection of a portion of the common and hepatic ducts, and an associated 
right hepatic artery injury 107-109_ The injuries at laparoscopic 
cholecystectomy 107-109 tend to be more extensive and higher in the duct 
system involving the bifurcation (Bismuth Grade 3 and 4) than open 
cholecystectomy, thus reducing the chance of a successful outcome to 
reconstruction 86.
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1.10 Bile leak
Bile leak after cholecystectomy may result in an intrabdominal collection, a 
biliary fistula, or biliary peritonitis, which is a life threatening complication. It 
may may arise from three sources: the cystic duct, a subvesical bile duct (duct 
of Luschka 128,138  ^or a bile duct injury (the latter usually being considered 
separately in classsification of complications). The subvesical duct of Luschka 
is a slender duct 1-2 mm in diameter passing from the right lobe of the liver in 
the gallbladder fossa to join the right hepatic or common hepatic duct 138-141, 
Because of its position and small size, it is particularly vulnerable during 
cholecystectomy 138. Anatomical studies using resin casting, dye injection, 
and histology of cadaver livers have shown that a subvesical duct is present 
in about 30-50% of patients, although using endoscopic retrograde or 
operative cholangiography it can only be detected in 1.3% of patients 128
The incidence of bile leaks after open cholecystectomy varies considerably 
amongst reports. In several recent large audit series of open cholecystectomy, 
there were no reports of bile leak 79,87,89,92,93,97,142, Clavien reported four 
(0.3%) bile leaks requiring re-operation in a series of 1,252 open 
cholecystectomies. Morgenstem reported 6  (0.5%) bile leaks resulting in 
fistulae in a series of 1,200 cholecystectomies, but all six resolved 
spontaneously. In a series of 196 cholecystectomies in which routine 
drainage of the gallbladder bed was used for an average postoperative of six 
days, bile was noted in the drain fluid in 19 (10%) cases, but only one (0.5%) 
required a second procedure 138. The source of bile leak after open 
cholecystectomy is often not positively identified but cystic duct leak is 
thought to be extremely rare.
Bile leak is reported with greater frequency after laparoscopic 
cholecystectomy 32,121,129,137,143, Wolf et al. I 18 reported 5 (1.3%)
clinically significant postoperative bile leaks in a series of 381 laparoscopic 
cholecystectomies; 4 were from the cystic duct, of which 3 required operation. 
Peck 105 reported 9 (1.9%) bile leaks in a series of 482 laparoscopic 
cholecystectomies, 6 of which were from the gallbladder bed. Walker 
reported 7 (2.7%) bile leaks in a series of 264 procedures 143.
There are a number of reasons why laparoscopic cholecystectomy may be 
associated with a greater risk of a bile leak. Clips rather than ties are used for 
the cystic duct. Cystic duct leak may occur because a clip becomes 
dislodged 144 because a clip does not completely traverse the duct, or 
because electrocautery injury results in delayed tissue necrosis of the cystic 
duct. In laparoscopic cholecystectomy, the gallbladder is usually dissected 
from the liver bed by the use of diathermy, whereas in open cholecystectomy, 
it is usually done by blunt or sharp dissection. It is possible, therefore, that the 
subvesical duct is at greater risk of accidental damage during laparoscopic 
cholecystectomy because of the depth of thermal injury caused by the use of 
electrocautery dissection.
1.11 Per- and Postoperative Haemorrhage
Significant haemorrhage may occur during or after a difficult open 
cholecystectomy 78,94,95  ^although in several large series there were no 
reports of major bleeding 79,88,91,142, Significant haemorrhage has been 
reported more frequently with laparoscopic cholecystectomy 
32,76,94,115,120,122 jn Cuschieri's initial series of 60 procedures, two patients 
required postoperative transfusion 145, and in Troidl's series of 400 patients, 
four had major haemorrhage 32. Haemorrhage during laparoscopic 
cholecystectomy is more difficult to control, as direct compression is not 
possible, suction removes the pneumoperitoneum, and spurting blood may 
obscure the telescope lens. "Blind" diathermy or clipping in an attempt to
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stop bleeding is said to be one of the causes of the increased incidence of bile 
duct injury during laparoscopic cholecystectomy I07,i08e In addition to 
bleeding from the cystic artery, hepatic artery or liver bed, bleeding may also 
occur from inadvertent injury to the epigastric artery, major vessels, solid 
organs, mesentery or omentum.
1.12 Problems related to laparoscopy
Laparoscopic cholecystectomy carries additional risks over open 
cholecystectomy which are intrinsic to the technique of laparoscopy. The most 
catastrophic and most feared complication of laparoscopy is injury to the major 
retroperitoneal vessels. In gynaecological series, the incidence of this is between 
3-10 per 10,000 closed laparoscopies 146-148 While the development of 
disposable trocars with spring-loaded safety shields and improvements in 
technique may have reduced the risk of this potentially fatal complication, 
reports on laparoscopic cholecystectomy indicate that they do not prevent it 
121,134,149,150 One reason for this is that the external safety shield of the trocar 
is often held back by a loose layer of peritoneum after it has entered the 
abdomen, leaving the sharp trocar exposed I49. In a survey throughout the 
United States, 36 major retroperitoneal vessel injuries (three of which resulted in 
death) were reported in a series of 77,604 laparoscopic cholecystectomies, an 
incidence of 5 per 10,000 134. These injuries were attributed mainly to trocar 
insertion. On the other hand, the 35 injuries to other intra-abdominal vessels 
(incidence 5 per 10,000) were atttributed mainly to Verres needle insertion. 
Vascular injury at the time of insertion of additional trocars should never occur, 
as these can be inserted under direct laparoscopic vision. Major vascular injury 
can be completely eliminated by routine use of open laparoscopy. Penfield 
reported no vascular injuries in almost 11,000 open laparoscopies performed by 
eighteen gynaecologists in the United States 151.
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Another serious complication of closed laparoscopy is hollow viscus perforation 
148 Perforation of the small bowel, colon, stomach, bladder, uterus, and ureter 
have all been reported. In the American survey of laparoscopic cholecystectomy 
previously alluded to, 109 bowel injuries (five of which were fatal) were 
reported, an incidence of 0.14% 134, which is similar to the incidence found in 
gynaecological experience 1^2 These injuries, which are typically unrecognised 
at the time of operation, often present late with peritonitis, intra-abdominal 
abscess, or enterocutaneous fisula I34, and may result in death 118. While bowel 
laceration can occur with open laparoscopy (six in 11,000 151), the major 
advantage this method has is that accidental perforation is usually recognised 
and can be repaired at the time of laparoscopy (four out of six 151).
An exceedingly rare but potentially life-threatening complication of 
laparoscopy is gas embolus, which occurs in less than 1 in 10,000 procedures 
153-155 ft js usually secondary to accidental intravascular injection of carbon 
dioxide during insufflation through a misplaced Veress needle, but has also 
been reported as a result of accidental placement of an air-cooled laser tip into 
a vessel156. Another rare complication resulting from peritoneal insufflation 
is a tension pneumothorax, which is usually due to a congenital defect of the 
diaphragm (a patent pleuroperitoneal canal) 157 although accidental 
perforation of the diaphragm by the gallbladder-retracting forceps is another 
cause 158
Another avoidable complication of either open or closed laparoscopy is 
herniation of omentum 125 or bowel 76,137,159-161 through the laparoscopic 
trocar site, which may result in small bowel obstruction 76,159-161 This is more 
likely to happen when the trocar site is enlarged to remove, for example, the 
gallbladder at laparoscopic cholecystectomy, and should always be 
accompanied by suture closure of the fascial defect.
1.13 Operative mortality
Open cholecystectomy has an excellent safety record. In a detailed analysis 
of mortality after all elective cholecystectomies performed in Denmark from 
1977 to 1981 (13,854 patients), the mortality for elective cholecystectomy in 
patients under 50 years was 0.02%, in patients 50-70 years old it was 0.47%, 
and in patients over 70 it was 2% 162 In an audit of all open 
cholecystectomies (42,474) performed in the two States in America in 1989, 
the mortality rate in those under 65 years of age was 0.03%, while in those 
over 65 years of age it was 0.5% 95. Six recent large reports with a total of 
3,630 patients, reported no deaths 79,87,90,92,94,97. jn five other recent 
reports with a total of nearly 5,000 patients 78,88,89,91,93? there were no 
deaths thought to be due to technical complications (such as common bile 
duct injury, bile leak, haemorrhage, or bowel injury). Deaths after 
cholecystectomy are usually related to the severity of the biliary disease (e.g. 
biliary peritonitis, severe pancreatitis, jaundice with cholangitis), concomitant 
medical problems (cardiovascular and respiratory disease, cirrhosis, and 
diabetes), and advanced age 78,80,88,89,91,93,162,163,
The mortality rate in most series of laparoscopic cholecystectomy is very low. 
In the multi-centre audit reports 29,76,77,81,130-132,134-137  ^ totalling over 
100,000 patients, the overall mortality rate was less than 0.1% (Table 1.4). A 
statewide report from Connecticut found that the overall mortality rate 
associated with cholecystectomy fell in 1991 after the introduction of 
laparoscopic cholecystectomy 29 This was partly due to a 29% increase in 
the frequency of cholecystectomy with the advent of the laparoscopic 
procedure. Nevertheless, the overall number of deaths from cholecystectomy 
did not increase after the introduction of the laparoscopic procedure. 
However, the worrying finding is the reporting of a significant number of 
deaths as a result of technical complications: haemorrhage 29,134,137^
A uthor Place Total No. 
of Patients 
n
Deaths 
n %
Iatrogenic 
Deaths 
n %
Cuschieri 77 Europe 1,236 0 0 0 0 .00
Litwin 130 Canada 2,201 0 0 0 0.00
Deveny 132 Oregon state 9,597 4 0.04 2 0 .02
Deziel 134 USA 77,604 33 0.04 18 0.02
Meyer 81 USA 1,518 1 0.07 0 0 .00
Larson 7 6 USA 1,983 2 0.10 0 0 .00
Airan 131 USA 2,671 3 0.11 1 0.04
Go 137 Netherlands 6,076 7 0.12 5 0.08
Orlando 29 Connecticut State 4,640 6 0.13 3 0.06
Sue 136 France 3,606 6 0.17 0 0 .00
FuIIarton 135 Scotland 1,655 8 0.48 2 0.12
TO TA L 106,711 63 0.06 26 0 .02
TABLE 1.4 Mortality in audit series of laparoscopic 
cholecystectomy.
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bile duct injury 2932,132,134,137? bile ieak 32,137^  an(j bowel injury 131,134,160. 
In Deziel's national survey of laparospic cholecystectomy at American 
hospitals, 18 of the 33 postoperative deaths were related to iatrogenic 
operative injury 134 and in the other multi-centre audit series there were a 
further eight deaths related to technical complications (Table 1.4).
In summary, open cholecystectomy has a very good safety record, with deaths 
being related complications of cholelithiasis, concomitant medical problems 
and advanced age. While the overall mortality rate from laparoscopic 
cholecystectomy is very low, the deaths resulting from iatrogenic 
complications gives cause for concern. It remains to be seen whether the 
incidence of iatrogenic deaths will diminish as the the experience of surgeons 
with the laparoscopic technique increases.
1.14 Common Bile Duct Stones
Patients with common bile duct (CBD) stones may be divided into two groups
according to presentation: firstly, patients who present primarily with signs or
symptoms (jaundice, cholangitis or pancreatitis) believed to be caused by
stones in the CBD; secondly, patients who present with symptoms related to
stones in the gallbladder but have CBD stones detected by preoperative or
operative cholangiography. Criteria requiring that pre-operative or per-
operative cholangiography be performed are a history of recent jaundice,
raised liver enzyme levels or dilatation of the CBD on ultrasonography 
166,168.
Ductal stones found by cholangiography during open cholecystectomy can 
be easily dealt with by CBD exploration. Operative cholangiography is 
technically more difficult during laparoscopic cholecystectomy than during 
open operation, and although success rates of 90% have been achieved
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145,169,170  ^most authors report rates below 50% with technical failure rates of 
10-25% 81,114,171 s and more than half of surgeons in the UK never perform 
operative cholangiography during laparoscopic cholecystectomy 172. 
Therefore, laparoscopic cholecystectomy patients with suspected CBD stones 
(abnormal liver function tests and/or dilated CBD on ultrasound) should be 
screened pre-operatively by intravenous cholangiogram (IVC) 128,173 or 
endoscopic retrograde cholangiography (ERCP) 128,166,168,174
Although laparoscopic common bile duct (CBD) exploration by the trans- 
cystic duct 175,176 Qr choledochotomy route 175,177 have been described, 
these methods still require to be fully evaluated. Most centres now choose to 
treat patients with CBD stones by pre-operative ERCP, endoscopic 
sphincterotomy (ES) and duct clearance before proceeding to laparoscopic 
cholecystectomy 166,168,178,179. The mortality rate of ERCP, ES and duct 
clearance is around 1% 180-183 Exploring the bile duct during open 
cholecystectomy seems to add little to the risk of death in patients aged under 
60 (mortality 0.3%), but it is associated with an increase mortality in patients 
aged over 60 (mortality 4% ) 162 Though the overall mortality (1%), morbidity 
(8%), and duct clearance rate (90%) associated with endoscopic treatment of 
CBD stones is comparable with that associated with open exploration of the 
bile duct, the endoscopic complications are largely independent of age 180-183. 
Thus patients at low risk from open surgery (aged under 60) who undergo 
laparoscopic cholecystectomy and endoscopic treatment of common duct 
stones may suffer greater morbidity and mortality than they would if they 
underwent open operation 184.
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1.15 Postoperative Pain and Pulmonary Function
Open cholecystectomy without the use of postoperative regional anaesthesia 
results in significant postoperative pain 53,54,185-188 This results in an altered 
pattern of breathing to minimize wound discomfort: coughing and 
diaphragmatic breathing is inhibited 189, abdominal and lower intercostal 
muscles undergo reflex spasm 190, and breathing becomes shallow and rapid, 
with loss of sighing 191. This abnormal breathing pattern results in a 
substantial reduction in pulmonary function 53,54^  an(j closure of small 
airways, which causes intrapulmonary shunting and hypoxaemia 192. 
Anaesthetic agents and opiates may also induce prolonged hypoventilation 
193 or episodes of obstructive sleep apnoea 194 resulting in oxygen 
desaturation in the postoperative period.
An oblique 54 or transverse 53 subcostal incision has been shown to result in 
less postoperative pain, and better pulmonary function than a midline incision 
for cholecystectomy. Furthermore, a small randomised trial has demonstrated 
that a 5-8 cm minilaparotomy incision results in less reduction in postoperative 
pulmonary function than a 15-20 cm subcostal incision 195.
A number of small studies have compared postoperative pain and/or 
pulmonary function after laparoscopic and standard open cholecystectomy 
195-203^  but au except one 195 of these studies were non-randomised, and 
several used historical controls 196,197,201,203. Laparoscopic 
cholecystectomy resulted in better pulmonary function 195,199-202  ^ lower pain 
scores 197,202^  an(j lower opiate analgesic requirement 196,201-203 than 
standard cholecystectomy. However, since these studies were not 
randomised, the results could have been subject to selection bias.
Furthermore, as analgesics were given on nurses’ assessment of pain, rather 
than a patient controlled device, there was a danger of observer bias.
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Three small randomised trials have compared postoperative pain and/or 
pulmonary function after minilaparotomy and laparoscopic cholecystectomy 
98,99,195 Laparoscopic cholecystectomy resulted in better postoperative 
pulmonary function 98,195^  jOWer analgesia requirement" ,  and lower pain 
scores 98 than minilaparotomy cholecystectomy. Although one study found 
no statistically significant difference in pain scores between the groups 99 and 
another found no difference in analgesia requirements " ,  these may have 
been false negative findings due to the small numbers in these studies. 
Intuitively, the laparoscopic technique might therefore be associated with a 
lower risk of pulmonary complications. However, in recent published series of 
open cholecystectomy the incidence of significant pulmonary complications 
was less than 1% 78,79,88,142
Wound pain, postoperative pulmonary function, arterial oxygen tensions, and 
the incidence of pulmonary complications after open cholecystectomy can all 
be substantially improved by either intercostal 194 interpleural 186,187 or 
thoracic epidural 185,188 bupivacaine. However, intercostal and interpleural 
blocks carry a small but significant risk of pneumothorax, and all three 
methods carry a significant cost due to increased time in the theatre. Hence, 
they are not widely used after cholecystectomy.
1.16 Recovery after Cholecystectomy
The principal advantage of laparoscopic over open cholecystectomy is said to 
be reduced hospital stay, and recovery period. Hospital stay after 
cholecystectomy is dependent on the severity and duration of postoperative 
pain and the time to resume oral fluids and diet. Additional factors are patients' 
social circumstances, and pre-conceived expectations of the "normal" duration 
of convalescence. Hospital stay for open cholecystectomy has been falling 
over the past decade and now averages six days in the British Isles 197,204
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while in the United States it is four days 95,203 Several American studies 
have reported even shorter average postoperative hospital stays of 3.2 days 
205, 2.8 days 2.5 days 206, 1.5 days 207, and 24 hours 58,59 Factors 
claimed to help reduce the length of hospitalization after open 
cholecystectomy are wound infiltration with bupivacaine, avoidance of the 
use of drains, early resumption of oral intake of fluids and diet, and early 
mobilization 59. The time to return to normal activity after standard 
cholecystectomy has not been well documented but is commonly believed to 
be about five 203 to six 205 weeks.
Several authors have reported that minilaparotomy cholecystectomy results in 
a shorter hospital stay and postoperative recovery period than standard 
cholecystectomy 1-5,57-60,208 jn many minilaparotomy series 3,5,60,72,99 the 
hospital stay was three to four days, and the time to return to normal activities 
three to four weeks. Ledet reported a series of 200 consecutive 
minilaparotomy cholecystectomies performed as day case procedure, with the 
time to return to work being four to five days for those in sedentary jobs, and 
21 days for those in heavy manual work (sometimes sooner for those allowed 
a light duty status by their employer)4. Goco and Chambers reported an 
average hospital stay of 1.2 days in a series of 450 consecutive 
minilaparotomy cholecystectomies 2  with average time to return to work of 18 
days 56
The average postoperative hospital stay reported after laparoscopic 
cholecystectomy ranges from 1 to 4.8 days 2932,77,81,130,135- 
137,197,203,205,209 jn many single centre series from the United States, the 
postoperative average stay was one day with some patients discharged on the 
day of operation 114,119,120,124,125,165,203. By contrast, the average 
postoperative stay in a state wide audit was 3.1 days, and in four large audit
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series from Europe it was 3 77, 3.5 137, 4 135, and 4.8 136 days. The median 
time taken to return to work or normal activity ranges from 5 to 14 days with 
an average of about 10 days 32.77,104,108,115,117,120,124,203. While these
results are substantially better than most surgeons experienced with open 
cholecystectomy, they are similar to the results mentioned above after 
minilaparotomy cholecystectomy. Both hospital stay and return to work are 
heavily influenced by social circumstances, cultural normals and the surgeon's 
and patient's pre-conceived expectation about a "normal" duration of 
convalescence: they are very subjective and variable indicators. In a report 
comparing recovery after laparoscopic cholecystectomy in America to that in 
France, patients in sedentiary occupations returned to work after 10 days in 
America, compared to 28 days in France 210.
1.17 Cost
Cholecystectomy is one of the most common elective surgical operations, with 
approximately 50,000 performed per year in the UK, and 600,000 per year in 
the United States. Therefore, the costs of the different methods of 
cholecystectomy have major implications for health economics. As a cause of 
hospitalization, gallstones are the most common and most costly digestive 
disease, with an annual estimated overal cost of more than $5 billion in the 
United States 21.
The two main factors determining the cost of a hospital admission for 
cholecystectomy are the theatre time and hospital stay 21 L Laparoscopic 
cholecystectomy is associated with extra costs due to equipment, disposable 
instruments, and longer operating time than open cholecystectomy 99 >203 but 
result in savings from reduced hospital stay. The estimated cost of 
laparoscopic cholecystectomy varies greatly depending on the operative time, 
whether disposable trocars and instruments are used, and whether
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emergency/urgent procedures are included whereas variations in the estimated 
cost of open cholecystectomy depend on the hospital stay.
Until recently, before resource management units have been introduced 
throughout the National Health Service, comparison of the costs of different 
treatments was almost impossible. As a result some have applied a simplistic 
approach of dividing all hospital costs by the total number of patient bed stay 
days, to derive a cost per patient per day. Using such a simplistic approach, 
Grace et al. 209 suggested that the laparoscopic method more than halved the 
cost of cholecystectomy (Ir£895 versus Ir£2210), while Attwood et al. 197 
suggested it reduced costs by about 30% (£1450 versus £1030). Two British 
studies using more detailed resource management information have compared 
the cost of laparoscopic and open cholecystectomy, although both were non 
non-randomised 212,213^  an(j one used historical data for open 
cholecystectomy with a mean hospital stay of 10 days 213. In the first of these 
studies, in which open cholecystectomy hospital stay was 6.5 days 212, 
laparoscopic cholecystectomy was found to be marginally more expensive 
when disposable instruments were used, while the second study, laparoscopic 
cholecystectomy was marginally cheaper, even allowing for the extra cost of 
disposable instruments 213.
A statewide analysis in Connecticut29 and a reported from a large private 
practice-based health maintenance organization in America 30 both found that 
the introduction of laparoscopic cholecystectomy had reduced the average 
cost of cholecystectomy by 25%. The average hospital stay for open 
cholecystectomy in these studies was nine 29 and six 30 days. By contrast, 
two American studies, in which average hospital stay for open 
cholecystectomy was less than three and a half days, found that the cost for 
laparoscopic cholecystectomy (surgeons' fees and hospital charges) was
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about 25-33% more than standard open cholecystectomy 205,214 Surgeons 
in the United States have increased professional fees for cholecystectomy by 
the laparoscopic method 215, but an additional cost to the American surgeon 
performing laparoscopic cholecystectomy is the higher malpractice insurance 
premium 215, reflecting the high incidence of technical complications. The 
increased used of endoscopic retrograde cholangiography both pre- and post- 
operatively 128,179,216,217 represents a hidden cost from the introduction of 
laparoscopic cholecystectomy .
As alluded to in section 1.2, the introduction of laparoscopic cholecystectomy 
has resulted in a lowering of the symptom threshold for cholecystectomy, with 
many surgeons perfoming cholecystectomy on asymptomatic patients with 
cholelithiasis 3132. Hence, even if the average cost of cholecystectomy is 
reduced by the laparoscopic method, total costs for health care organisations 
and the health service resulting from cholecystectomy are likely to be higher 
because of an increase in the number of cholecystectomies performed. The 
report from a private practice-based health maintenance organization in 
America found a 60% increase in the cholecystectomy rate after the 
introduction of laparoscopic cholecystectomy. Hence, although the unit cost 
of cholecystectomy fell by 25%, the total expenditure on gallbladder disease 
increased by 11%. The statewide analysis in Connecticut found that from 
1989 to 1991, the cholecystectomy rate increased by 30%, and total 
expenditure on cholecystectomies increased from $60 million to $90 million.
The increased used of endoscopic retrograde cholangiography 128,179,216-218 
both pre- and post-operatively to screen for common bile duct stones 
represents another hidden cost from the introduction of laparoscopic 
cholecystectomy.
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1.18 Randomised Trials in Surgery
It is vital that the efficacy of all new medical interventions be judged on the 
highest quality of evidence, and that they be compared with the currently 
accepted method(s), in order to save current and future patients from the 
therapeutic passions of clinicians developing new treatments. The greater the 
scale of intervention, the more irreversible the consequences of such 
invasions, then the greater is the entitlement of the public to unequivocal 
evidence. There is a hierarchy in the cogency of evidence that may be 
adduced in defence of medical interventions 219. Of lowest order is the 
anecdotal case report. Higher than this would rank case series without 
controls or series with controls from published papers. Higher still might be 
comparisons with computer data bases or case-controlled observational 
studies; and the summit of the pyramid is the randomised controlled clinical 
trial.
Randomisation avoids bias in treatment allocation - prognostic factors, 
whether known or unknown, tend to be balanced between treatment groups. 
Thus, randomisation guarantees the validity of statistical tests of significance. 
In nonrandomised studies, on the other hand, chance or bias can result in the 
selection of patients for innovative treatment who are either the least diseased 
or the most severely affected. Depending on the case mix, a treatment that has 
no effect can appear to be effective or toxic when historical controls are used. 
With improvement in diagnostic accuracy and the understanding of disease 
that has occurred with the passage of time, today's patients are identified 
earlier in the natural history of their disease. Recently selected case series 
therefore often have patients who are less ill and an outcome that is 
considerably better than that of past case series, even without changes in 
treatment.
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The first randomised controlled trial, inspired by Bradford Hill and conducted 
by the Medical Research council was reported in 1948 and evaluated 
streptomycin in the treatment of pulmonary tuberculosis 220. The first 
randomised controlled trial in surgery, which compared vagotomy with 
gastroenterostomy or antrectomy versus subtotal gastrectomy in the elective 
treatment of duodenal ulcer, was reported by Goligher in 1964 221. This 
report spurred surgeons all over the world to conduct randomized controlled 
trials but it is still true that most clinical reseach in surgery relies on 
comparisons with historical or contemporary non-random controls 222
Randomised controlled trials are ideally suited to the testing of new drugs 
because the trial can usually be double-blind and placebo controlled.
Objective testing of this rigour is is an absolute necessity before any new 
pharmaceutical product is released by the Committee of Safety of Medicines 
(CSM) in the UK and the Food and Drug Administration (FDA) in the USA.
By contrast, "blinding" of the surgeon can never be achieved, and can only 
sometimes be achieved for the assessor and the patients. Recruitment for 
surgical trials is usually slower than for many drug trials and financial support 
is frequently more difficult to raise, so that it is more difficult to mount trials of 
sufficient size to produces clear results.
Historically, the introduction of new surgical procedures result from the 
initiative of individual surgeons, and the new technique was usually tested by 
comparing the results with historical controls. The history of surgery is littered 
with examples of surgical practice where less rigorously evaluated procedures 
have been found to be ineffective. Examples are the Halsted radical 
mastectomy 223, gastric freezing for peptic ulceration, carotid body 
denervation for bronchial asthma, prophylactic porto-caval shunt in patients 
with oesophageal varices, and periarterial sympathectomy 224.
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Nevertheless, randomised controlled trials are used less frequently in the 
evaluation of surgical procedures for several, at least partly valid, reasons.
One of the principal determinants of surgical outcome is the skill and 
experience of the surgeon. This factor has been highlighted in two major 
studies of outcome of surgery for large bowel cancer 225,226 Surgical 
experience, a strong variable determining outcome, is inevitably going to be 
greater for the standard method and therefore not directly comparable with 
that for the new technique, particularly during any learning curve. Further 
bias accrues in that new surgical techniques are usually introduced by 
enthusiastic and skilled surgeons whereas the standard technique is practised 
by all surgeons in that specialty. There is no statutory control over the 
development and introduction of new operative techniques. As a result, new 
surgical techniques are introduced to clinical care much earlier than is the case 
for new drugs. Difficulty then arises in deciding when a randomised trial 
should be commenced. Chalmers has argued strongly for randomisation of the 
first patient227 This seems impractical 228. Since there is a learning curve for 
each new operation, randomisation of 'the first patient' to a new procedure 
would introduce selective bias against it. The investigator must be allowed to 
exercise judgement about the earliest possible point at which a randomised 
controlled trial can begin. An example of starting a trial too early in the 
development of an operation was the Veterans Administration trial of 
coronary artery bypass surgery, which was criticized because the poor early 
operative results did not reflect current experience 229.
One of the theoretical prerequisites for the conduct of a randomised controlled 
trial is that a state of ''clinical equipoise" exists 23°. That is to say, that on the 
available data, neither treatment arm of a study should be established as 
preferable to the other 23 K The principal objection to a randomised controlled 
trial of laparoscopic cholecystectomy, has been that surgeons' early
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experiences of laparoscopic cholecystectomy have been so favourable in 
terms of less postoperative pain, rapid hospital discharge, and rapid return to 
normal activity that they felt the benefits of the procedure were obvious. 
Maybe partly as a result of the the glamour of the new technology (miniature 
video cameras, lasers etc.), the media has taken considerable interest in the 
new technique of laparoscopic cholecystectomy, and portrayed the keyhole 
procedure as having huge advantages over the "old-fashioned" standard 
procedure. This has meant that patients have come demanding the new 
operation. It is not surprising, therefore, that there has been no randomised 
trials comparing laparoscopic and standard open cholecystectomy.
1.19 Results of Randomised Trials of Laparoscopic versus 
Minilaparotomy Cholecystectomy
Two small randomised trials comparing laparoscopic and minilaparotomy
cholecystectomy were published in 1992, one from Germany 98, and one from
Canada 99
German Study
A randomised trial of laparoscopic versus minilaparotomy cholecystectomy 
has been recently reported in the German literature 98 In this study, only 77 
patients out of a total of 325 cholecystectomies performed during the one 
year study period were randomised. Pain scores were significantly lower in 
the laparoscopic group on the first three postoperative days. Forced vital 
capacity was significantly better in the laparoscopic group on the first two 
postoperative days, but by the third day pulmonary function in the two 
groups was similar. However, the difference in analgesia rquirement between 
the groups was not significant. This was probably due to the small size of the 
study and the method of assessment: two analgesics were used and analgesia 
requirement was not patient-controlled. Even though all patients were kept in
hospital a minimum of 3 days as part of the postoperative assessment, hospital 
stay was significantly shorter in the laparoscopic group (3.5 versus 5.8 days). 
One major complication occurred in each group. One patient in the 
laparoscopic group developed postoperative haemorrhage, which required 
subhepatic drainage, but did not require transfusion. The bile duct was 
injured in one patient in the minilaparotomy group, requiring 
hepaticojejunostomy. The mean duration of surgery was 101 minutes in both 
groups.
Canadian Study
There is only one randomised trial of laparoscopic versus minilaparotomy 
cholecystectomy reported in the English literature 99 In this study, with 62 
evaluated patients, median postoperative hospital stay was 2 days for 
laparoscopic cholecystectomy and 3 days for minilaparotomy 
cholecystectomy while the median time to return to normal activity was 9 and 
14 days respectively. Analgesia requirement was also lower after laparoscopic 
cholecystectomy.
However, the study has been strongly criticised and several factors limit its 
value 232,233. Firstly, only 70 patients were recruited by 8 surgeons in 5 
University hospitals over a one year period, and therefore the patients were 
highly selected. The withdrawal from the study after randomisation by seven 
patients in the minilaparotomy group but only one in the laparoscopic group 
(Fisher's exact test, p=0.013) raises questions about the patients' perceptions 
of the relative advantages of the two procedures.
Secondly, the trial was stopped early, after 70 rather than the predetermined 
100 patients had been recruited "because significant differences in primary 
endpoints had been reached". It is well known that trials that were stopped
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because p-values became significant are too small and difficult to interpret234. 
In this case, the important p-values relating to the stated primary endpoint 
were only just less than 0.05 (shorter mean duration of convalescence, 
p<0.04; and return to normal activities, p=0.03) and it is likely that any 
appropriate analysis taking into account the fact that there could have been 
more than one assessment (e.g. Bonferroni correction) would yield non­
significant results. Even with 100 patients, the power of this study would 
have been extremely low. Based on preliminary studies (before the trial) and 
reasonable estimates of convalescence outcome, Barkun et al. calculated that 
50 patients in each group should enable the detection of a difference in 
duration of convalescence of 18 days, with a=0.05 and statistical power of 0.8.
Thirdly, the three outcome measures (opioid analgesia use, hospital stay, and 
duration of convalescence) which showed significant intergroup differences 
in favour of laparoscopic cholecystectomy were all dependent on judgments 
by unblinded carers, and therefore open to observer bias. On the other hand, 
postoperative pain (measured by McGill questionnaire and not dependent on 
observer judgment) did not differ significantly between the groups. Also, 
fewer patients in the minilaparotomy group complained of right shoulder pain 
(5% versus 33%).
Fourthly, health gains after cholecystectomy were assessed using three 
different instruments to measure quality of life. Contrary to the 
recommendations of the developers of the Nottingham Health Profile 
Questionnaire 235, the answers were given equal weights and combined into a 
single index. Furthermore, no intergroup statistical comparison of quality-of- 
life scores were reported. Instead, by reporting within-group statistical 
comparison of postoperative versus pre-operative values, it is implied that 
quality of life scores improved faster in the laparoscopic group.
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Finally, the incision size used in the minilaparotomy cholecystectomy patients 
is not stated. Also, one surgeon used a midline incision, which is associated 
with greater postoperative pain and depression of pulmonary function than a 
transverse incision 53
1.20 Metabolic response to cholecystectomy
The stress of surgery evokes a wide variety of biochemical and physiological 
changes including production of cytokines 9,11,236,237 ancj acute phase 
proteins 238, increase in the levels of "stress hormones 10,239,240 ioss Qf  
muscle protein 241, increased vacular permeability 242, and changes in white 
cell count subsets 243-245. Although some of these responses are considered 
to be a homeostatic defence mechanism, some of the consequences such as 
the catabolic state, are thought to be deleterious 241.
It has been shown that the magnitude of the metabolic response to injury is 
proportional to the degree of the surgical trauma 8-11. It has been postulated, 
therefore, that the reduction of "access trauma" by the laparoscopic technique 
might diminish the metabolic response 145. However, diagnostic laparoscopy 
alone is associated with a substantial hormonal and glycaemic response, which 
may be evoked by the stimulus of peritoneal distension 246. Furthermore, the 
magnitude of the metabolic response has been shown to correlate with the 
duration of surgery 9,237^  which for laparoscopic cholecystectomy, is longer 
than open cholecystectomy 81,99,203.
Three recent studies have compared selected aspects of the metabolic 
response to laparoscopic and standard cholecystectomy using historical 201 
and non-randomised 198>202controls. A greater rise in serum levels of 
interleukin-6 20 *, and C reactive protein 201>2°2 and the erythrocyte 
sedimentation rate 202 occurred after standard cholecystectomy compared to
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laparoscopic cholecystectomy, but there was a similar cortisol response after 
both procedures 198,201 One of the studies reported a trend towards lower 
plasma levels of adrenaline after laparoscopic cholecystectomy 201, while 
another of these three studies found higher urinary catecholamine breakdown 
products (vanillylmandelic acid) after laparoscopic cholecystectomy 202.
The metabolic response to minilaparotomy cholecystectomy has not been 
previously described.
1.21 Ventilatory and blood gas changes during laparoscopic 
cholecystectomy
Until the advent of extended therapeutic laparoscopic procedures such as 
laparoscopic cholecystectomy, most laparoscopies were brief and performed in 
young, otherwise healthy, gynaecological patients. Ventilatory changes in 
these patients have been extensively studied 247-250< Carbon dioxide (CO2) 
absorption during laparoscopy performed under local anaesthesia results in an 
increased respiratory drive, with minute ventilation increasing by a mean of 
one 1/min and thus maintaining arterial CO2 tension (Paco2) within the normal 
range 251. On the other hand, during laparoscopy under relaxant general 
anaesthesia with fixed minute ventilation volume, mean Paco2 is reported to 
rise by 0.6 - 1.4 kPa 247,250,252-254
With the increasing popularity of minimally invasive general surgery, many 
laparoscopic procedures now require long periods of peritoneal insufflation, 
and are often performed on patients who are older and have respiratory 
disease. Two recent studies have suggested that greater ventilatory changes 
occur in these patients 13»14. Wittgen et al compared the changes in 20 
normal patients to that in 10 patients with cardiorespiratory disease 13.
During laparoscopic cholecystectomy, Paco2 rose by 0.8kPa in the normal 
patients (without increasing ventilation), while in patients with
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cardiopulmonary disease P&coi rose by 2.0 kPa despite an increase in minute 
ventilation of 1.2 litres. The corresponding changes in end-tidal CO2 tension 
(Pec02) were much less and did not fully reflect the changes in P&coi'- in 
normal patients P e ' c o 2  increased only by 0.3 kPa, while in the patients with 
cardiorespiratory disease, it increased only by 0.6 kPa. In contrast, in a study 
of gynaecological laparoscopy 252, mean (Paco2 - Pec02) did not change 
significantly with CO2 pneumoperitoneum. Wittgen et al concluded that end- 
tidal measurement of P c o 2 was a poor indicator of changes in Paco2- Marked 
within-patient variability in (Paco2 - Pec02) during anaesthesia has also been 
shown in a study of patients undergoing major surgery 255. Indeed, within- 
patient variations in (Paco2 - P e ’c o 2)  were comparable to or greater than the 
inter-patient differences.
In the second study of blood gas and ventilatory changes during laparoscopic 
cholecystectomy, Liu et a l 14 found that P e ' c o 2  and Paco2 both increased by 
a mean of 1.4 kPa during laparoscopic cholecystectomy, with 13 out of 16 
patients requiring an increase in minute ventilation to maintain Peqoi below 6 
kPa. They claimed that there was good agreement between paired P e ' c o 2  and 
Paco2 measurements, but their data do not support this statement. On 
analysing their results, it is apparent that 95% of patients had a Paco2 
between 0.42 kPa lower to 1.08 kPa higher than paired Peqoi measurements.
In a pig model of laparoscopic cholecystectomy, Paco2 increased by 1.9 kPa 
and carbon dioxide output by 30% of baseline values 12. In a canine model 
of prolonged laparoscopy (2 hours), the effects of CO2 and helium 
pneumoperitoneum were compared 256. Even with a 57% increase in minute 
ventilation to maintain a constant Pe*co2, CO2 pneumoperitonum was 
associated with a significant rise in Paco2 and (Paco2 - Pecoi)- The rise in 
minute ventilation requirement, Paco2> and (Paco2 - Peqoi) was greater in
dogs with papain-induced pulmonary emphysema, supporting the previously 
mentioned findings of Wittgen et al in patients with pulmonary disease 
undergoing laparoscopic cholecystectomy 13. Intra-operative blood gas 
monitoring may be advisable in patients with severe respiratory disease, as 
they may have larger differences between P a c o 2  and P e ' c o 2  and a greater 
tendency to retain CO2 13.
1.22 Helium pneumoperitoneum
The adverse effects of a CO2 pneumoperitoneum, particularly in patients with 
respiratory disease, have prompted a search for an alternative gas to carbon 
dioxide for insufflation of the abdomen. The ideal pneumoperitoneum gas 
requires a number of properties. Firstly, it should be chemically, 
physiologically, and pharmacologically inert. Secondly, it should not support 
combustion. Intestinal gas contains substantial amounts of hydrogen and 
methane 257, and since hydrogen is one of the most diffusible gases known, it 
can diffuse across the bowel wall into the abdominal cavity. The explosion 
threshold of hydrogen in a gas supporting combustion is only 5.5% by 
volume 258, with the activation energy required to initiate explosion with 
these gases being a fraction of that produced by an electrocautery device 
259 Therefore, it is paramount that the gas used during therapeutic 
laparoscopy, must not support combustion. Thirdly, it should also be highly 
water soluble, so that if an air embolism occurs, it will rapidly dissolve in the 
blood stream, rather than forming an "airtrap" in the right ventricle.
The two gases most widely used nowadays for laparoscopy are CO2 and N2O, 
although air and O2 have also been used in the past. CO2 has been shown to 
result in a greater pain stimulus than N2O, due to CO2 dissolving on the 
peritoneal surface to form carbonic acid 260-262, CO2  also has the 
disadvantage, demostrated in this and other studies 12-14 that its absorption
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from the peritoneal cavity results in an increased ventilatory requirement. The 
principal advantage of CO2 over other gases is that it is highly water soluble. 
This gives it a much higher safety margin than any other gas in the rare event 
of gas embolism. Also, CO2 that is inadvertently insufflated into the 
abdominal wall is rapidly absorbed. N2O pneumoperitoneum does not result 
in any changes in arterial blood gases. However, because it supports 
combustion, N2O can only be used in laparoscopic procedures not requiring 
diathermy 263.
Helium has recently been suggested as an alternative insufflation gas to CO2 in 
patients with severe respiratory disease 256,264 Helium is an inert gas, which is 
chemically, physiologically and pharmacologically inert, and does not support 
combustion. Its physical property of low airflow resistance is utilized in 
patients with narrowed airways 265, and also to operate intra-aortic balloon 
pumps. It is thus readily available in hospitals. Two animal model studies have 
confirmed the suitability of helium for insufflating the abdomen during 
laparoscopy, and showed that it does not alter ventilation requirements 256,266 
or cause hypercarbia and acidosis. In the first human study of helium 
pneumoperitoneum, Leighton et al. compared ventilatory changes.
The only drawback of helium is that it is relatively insoluble. In order to 
reduce the risk of insoluble gas vascular embolism with helium 
pneumoperitoneum, the open technique of laparoscopy might be used 151, 
which avoids the risk of insufflation through a misplaced Veress needle. 
Alternatively, the initial pneumoperitoneum could be created using CO2 , and 
once the pneumoperitoneum is safely established, CO2 could be exchanged 
for helium as the maintenance gas.
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Chapter 2
LAPAROSCOPIC VERSUS OPEN 
CHOLECYSTECTOMY AND THE NEED FOR A 
RANDOMIZED TRIAL: A SURVEY OF 
SURGEONS AND ETHICAL COMMITTEES 
IN THE BRITISH ISLES
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2.1 INTRODUCTION
Laparoscopic cholecystectomy was first performed in 1988. By the end of 
1991, over a half of the general surgeons in the British Isles had begun 
performing laparoscopic cholecystectomies, and a further third of the surgeons 
intended to introduce the laparoscopic technique i72. The assessment of 
laparoscopic cholecystectomy up to 1992 was based largely on case series 
without controls 76,77,81 s ancj on a few small case studies with historical 
203,209 or non-randomised 72 controls. Randomised controlled trials (RCTs) 
are the optimum method for assessing any new intervention and the 
investigatory tool which can best avoid selection and observation bias 267. 
However, the response of patients, the media, and surgeons to laparoscopic 
cholecystectomy has been so favourable that some surgeons have argued that 
it would be impossible to recruit patients to a RCT comparing laparoscopic 
and open cholecystectomy 268,269 Some even have gone as far as stating 
that a RCT would be ethical 268.
Therefore, a survey was carried out in April 1992 to ascertain the views of 
general surgeons and ethical committees in the the British Isles on the 
necessity and ethics of a RCT comparing laparoscopic and open 
cholecystectomy.
2.2 METHODS
From a computer database of all consultant general surgeons in the British 
Isles (obtained from Ethicon, Edinburgh, UK), two hundred names were 
randomly selected. These surgeons were sent a brief one page questionnaire 
in April 1992 (Appendix 1). The questions related to surgeons' views on the 
safety of laparoscopic cholecystectomy, the need for a RCT, the practicality 
and ethics of a RCT, their interest in participating in a trial, and their choice of 
operation if they were to require cholecystectomy. Answers were in the form 
of a 4 or 5 point response scale. The effect of surgeon seniority and 
laparoscopic cholecystectomy experience on the answers was assessed using 
Spearman rank order correlations.
In addition, forty hospitals (20 teaching and 20 district general hospitals) were 
selected at random from a list of all hospitals in the UK. Ethical committee 
chairmen were identified by telephone enquiry and sent a hypothetical 
application for ethical approval to carry out a RCT comparing standard 
cholecystectomy and laparoscopic cholecystectomy.
2.3 RESULTS
A reply was obtained from 117 (59%) surgeons of which 5 were excluded (3 
retired, 2 not general surgeons). 56% were district general hospital surgeons, 
35% teaching hospital surgeons, and 9% were academic surgeons. A 
representative spread of surgeon seniority was found among responders 
(median number of years appointed 12, range 1-30). A third of surgeons had 
not performed any laparoscopic cholecystectomies, a third had performed up 
to 20, and a third more than 20 (Figure 2.1).
42% thought a RCT comparing laparoscopic cholecystectomy with standard 
cholecystectomy was necessary, while 51% thought a RCT comparing 
laparoscopic cholecystectomy with minilaparotomy cholecystectomy was 
necessary (Table 2.1). A total of 58% thought either one or both of these trials 
was necessary. 31% of surgeons thought an RCT would be unethical. In 
contrast, 24 ethical committees gave approval to the concept of a RCT 
comparing laparoscopic cholecystectomy and standard cholecystectomy, 
while only 3 considered that a RCT was unethical (13 refused to comment on 
a hypothetical application). A suprisingly high percentage of surgeons (45%) 
expressed interest in participating in an RCT.
63% of surgeons were satisfied with the safety of laparoscopic 
cholecystectomy, while 28% were unsure of the safety of laparoscopic 
cholecystectomy, and 10% concerned about the safety of laparoscopic 
cholecystectomy. Surgeons with greater experience in laparoscopic 
cholecystectomy tended to be more satisfied with the safety of the procedure 
(r=0.56, p<0.001), less convinced of the need for a RCT comparing 
laparoscopic cholecystectomy with standard cholecystectomy (r=0.36, 
p<0.001, see Figure 2.2) or minilaparotomy cholecystectomy (r=0.41, 
p<0.001), less interested in participating in a RCT (r=0.28, p=0.003), and
% of 
Surgeons 15
0 1-10 11-20 21-30 31-40 41-50 51-100 >100
Number of Laparoscopic 
Cholecystectomies Performed
FIGURE 2.1 Number of laparoscopic cholecystectomies 
performed by surgeons responding to 
questionnaire
M inilaparotom y
Cholecystectomy
Standard
Cholecystectomy
Very necessary 22% 21%
Probably necessary 30% 19%
Unsure 12% 12%
Probably unnecessary 24% 30%
Totally unnecessary 13% 18%
TABLE 2.1 Response to the Question: ”Do you think there is a 
necessity for a randomised controlled trial 
comparing laparoscopic cholecystectomy with 
open cholecystectomy (minilaparotomy or 
standard)?:
Number of Laparoscopic 
Cholecystectomies Performed:
□  None £23 1-20 □  >20
40
3 0
% o f  20 
Surgeons
10
0
3 I i / / iibii
Very Probably Unsure Probably Totally
necessary necessary unnecessary unnecessary
Surgeons' Answers
FIGURE 2.2 Effect of laparoscopic cholecystectomy
experience on response of surgeons to the 
question "Do you think there is a necessity for a 
randomised controlled trial comparing 
laparoscopic cholecystectomy with standard 
cholecystectomy?"
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tended to chose laparoscopic cholecystectomy as their preferred choice of 
operation (r=0.30, p=0.001). Junior consultants tended to have performed 
more laparoscopic cholecystectomies (r=0.29, p=0.002), but surgeon seniority 
and type of consultant post (district general hospital, teaching hospital, 
academic appointment) did not significantly affect surgeons views on these 
issues.
Surgeons were asked "If you were admitted to a hospital not known to 
yourself for an elective cholecystectomy (albeit an unlikely scenario) and 
were offered laparoscopic or open cholecystectomy, which procedure would 
you choose?": 49% chose laparoscopic cholecystectomy, a further 21% chose 
laparoscopic cholecystectomy only if they could guarantee the surgeon had 
had substantial experience of laparoscopic cholecystectomy without major 
complications, while 28% chose open cholecystectomy (2% were undecided).
64
2.4 DISCUSSION
In contrast to previously expressed views 268,269  ^ this survey showed that in 
April 1992, there was a body of support for a RCT comparing laparoscopic 
and open cholecystectomy, with 58% of surgeons expressing the view that a 
randomised controlled trial was necessary and 45% of surgeons expressing 
some interest in participating in a RCT. Furthermore, the majority of ethical 
committees would give approval in 1992 for a RCT to assess laparoscopic 
cholecystectomy.
Surgeons with more experience of laparoscopic cholecystectomy tended to be 
less inclined towards the need for a RCT. This finding might be interpreted in 
two ways. On the one hand, it could be argued that surgeons performing 
laparoscopic cholecystectomy become aware of a clear and obvious benefit of 
the laparoscopic technique in terms of a more rapid postoperative recovery, 
and therefore feel less inclined to the need for a RCT to objectively asess the 
benefits of the technique. On the other hand, it could be argued that there is a 
difference in attitude between surgeons who have started performing 
laparoscopic cholecystectomy, and surgeons who have not; that surgeons 
with an enthusiasm for new techniques have started performing laparoscopic 
cholecystectomy before rigorous evaluation, and clear evidence proven 
advantage for the method. Such surgeons might be less inclined to the use of 
RCTs, feeling that they restrict the advance of surgical innovation.
In difficult clinical situations, the question a surgeon often has to ask himself, 
is what decision would he take if he or a close relative of himself was the 
patient. Interestingly, in this survey less than half of the surgeons would 
unreservedly have chosen the laparoscopic technique if they were to require 
cholecystectomy themselves, with over a quarter of surgeons choosing open 
cholecystectomy.
In conclusion, this survey showed that in April 1992 there was wide support 
amongst the surgical community for RCTs comparing laparoscopic 
cholecystectomy and open cholecystectomy, and that contrary to previous 
suggestions, such trials would receive the approval of ethical committees in 
the British Isles.
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Chapter 3
LAPAROSCOPIC VERSUS 
MINILAPAROTOMY CHOLECYSTECTOMY: 
A RANDOMISED TRIAL
3.1 INTRODUCTION
Laparoscopic cholecystectomy was first performed by Mouret in France in 
1987. Since then the technique has replaced open cholecystectomy as the 
standard treatment for symptomatic cholelithiasis 21. The perceived 
advantages of laparoscopic cholecystectomy are less postoperative pain, 
reduced hospital stay and a more rapid return to normal activity. However, 
without rigorous evaluation, the supposed benefits of the laparoscopic 
technique remain unproven. Audit has shown an increased incidence of bile 
duct injury after laparoscopic cholecystectomy 134-136 other serious 
complications include major vascular injury 150,270 and viscus perforation 
81,118 during Veress needle or trocar insertion. These increased risks require 
that the postulated benefits of the laparoscopic technique are assessed 
objectively 75.
Surgeons have been reluctant to conduct clinical trials comparing 
conventional with laparoscopic cholecystectomy 268 However, a small 
transverse subcostal incision ("minilaparotomy") for open cholecystectomy 
has been shown to result in a more rapid postoperative recovery than a 
standard incision 1_7. A randomised trial was therefore undertaken to 
compare outcomes following laparoscopic and minilaparotomy 
cholecystectomy.
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3.2 PATIENTS AND METHODS
Seven consultants in five hospitals (Western Infirmary, Royal Infirmary, 
Gartnavel General Hospital, Southern General Hospital, Glasgow and 
Crosshouse Hospital, Kilmarnock) participated in this trial, which was 
approved by the relevant hospital ethical committees. All had previous 
experience of laparoscopic cholecystectomy and all except one had assisted 
at or performed more than thirty procedures. Four surgeons began recruiting 
patients to the trial in August 1991, a further three joined the study in 1992, 
and recruitment was completed at the end of March 1993. All patients 
undergoing elective cholecystectomy for symptomatic cholelithiasis were 
considered for entry into this trial; this included patients with acute 
cholecystitis and acute pancreatitis who underwent delayed interval 
cholecystectomy. Patients requiring urgent surgery for empyema or 
perforation, those with common bile duct stones and those with extensive 
previous upper abdominal surgery were excluded. Patients with abnormal 
liver function tests or a dilated common bile duct on ultrasound were recruited 
into the trial only if a pre-operative intravenous or endoscopic retrograde 
cholangiogram was normal. After giving informed consent, patients were 
randomised on the day before operation by the use of numbered sealed 
envelopes, stratified by surgeon.
Laparoscopic cholecystectomy was performed using a four trocar technique 
with electrocautery dissection. Minilaparotomy cholecystectomy was 
performed using a five to ten centimetre transverse subcostal incision 
depending on body habitus 5. In both groups, patients received antibiotic 
prophylaxis (a single dose of intravenous Cefuroxime 1.5g), subcutaneous 
heparin (5,000 i.u. twice daily), and local anaesthetic wound infiltration at the 
end of the procedure (20 mis of 0.5% bupivacaine). A consultant was present 
at all operations. Only one surgeon had a policy of routine cholangiography;
the remainder used it only when there was a suspicion of bile duct stones at 
operation.
Analgesia requirement and pain scores
Postoperatively, patients were given intravenous morphine by a disposable 
patient-controlled analgesia device 271,272 (Figure 3.1), which gave a bolus 
dose of one mg of morphine; the refill time until the next full dose was six 
minutes, yielding a maximum rate of 10 mg per hour. A standard explanation 
of how to use this device was given to each patient on the day before 
operation, along with an information sheet. On the second postoperative day, 
patients were also given simple oral analgesics on demand. At 24 and 48 
hours postoperatively, patients were shown a 100 mm linear analogue pain 
scale: labelled from "pain free" to "worst pain I could possibly imagine"273 
and asked to mark the pain they experienced on sitting up from the lying 
position and on coughing. They were also asked to assess this pain on an 
ordinal four-point scale (none, mild, moderate, severe).
Pulmonary function
Forced vital capacity (FVC), forced expiratory volume in one second (FEV1), 
and peak expiratory flow rate (PEFR) were assessed using a Respiradyne 
pulmonary function monitor 274 (Figure 3.2), pre-operatively and 24 and 48 
hours postoperatively. All measurements were performed on sitting patients 
after a standard explanation. Five measurements were taken on each 
occasion, and the best of the five values was recorded. Postoperative 
pulmonary function was expressed as a percentage of the pre-operative value.
Oxygen saturation
After patients had returned to the ward from the recovery area, no routine 
oxygen supplementation was given. Oxygen saturation was monitored 
continuously with an Ohmeda Biox 3700 Pulse Oximeter after return to the
FIGURE 3.1 Disposable patient controlled analgesia device
FIGURE 3.2 Respiradyne portable pulmonary function monitor
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ward. The audible low saturation alarm was set at 86% 275 . If oxygen 
saturation fell to this level, oxygen supplementation was given. Oxygen 
saturation on breathing air was recorded every hour for 16 hours. In the case 
of patients who required oxygen supplementation, this was performed by 
removing the oxygen mask for 5 minutes before taking the reading.
Complications
Wound infection was defined as presence of cellulitis, or pus discharge from 
the wound. A major postoperative complication was defined as any 
complication which prolonged hospital stay, required admission to intensive 
care unit, or required a further interventional procedure.
Hospital stay and return to normal activity
Before hospital discharge, patients had to tolerate a full diet, be able to dress 
themselves, be fully mobile around the ward, require only oral analgesia, and 
be satisfied that they could manage at home. Patients were reviewed at the 
outpatient clinic at 10 days and 4 weeks postoperatively.
To assess return to normal activity, patients were sent postal questionnaires at 
one, four, and twelve weeks after operation, with reminders for non­
responders two and four weeks after the last two questionnaires. Self­
completion was used rather than interview to avoid observer bias and 
minimise cost. The questionnaires contained questions about return to their 
normal activity (paid employment, looking after the home, social life, sex life, 
interests and hobbies), a modified version of the SF-36 health survey 
questionnaire 276,277 ancj the hospital anxiety and depression scale (HADS) 
278. Questions 9 (i-ix) and 10 in the SF-36 were omitted to avoid repetition of 
similar questions in HADS; the remaining seven SF-36 dimensions were 
scored from 0 (worst score) to 100 (best). In view of the patients’ recent 
operations, the SF-36 questions in the first questionaire were amended to
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focus on the time period since returning home from hospital, and the second 
and third questionnaires on the week immediately preceding the 
questionnaire. The HADS responses were converted into two separate scores 
for anxiety and depression (best score 0, worst 21). Finally, patients were 
asked to grade the outcome of the operation on a five point scale (excellent, 
good, fair, poor, very poor) and also their satisfaction with the appearance of 
the operation scars (very satisfied, moderately satisfied, barely satisfied, 
moderately dissatisfied, very dissatisfied).
Costs
A detailed breakdown of theatre, ward, investigation, and staffing costs was 
obtained for the financial year April 1991 to March 1992 from the resource 
management units of the two main hospitals involved in this study (Western 
Infirmary and Royal Infirmary, Glasgow). Formulae used to calculate costs are 
shown in Figure 3.3. Costing breakdowns from both hospitals were similar 
(Table 3.1). The National Health Service cost of hospital admission for 
cholecystectomy for each patient was then estimated on the basis of theatre 
time, hospital stay, and additional tests or treatment using an average of the 
costs obtained from the Western and Royal Infirmaries. Costing did not 
include previous investigation or out-patient follow-up. The resulting theatre 
costs were £369 per hour, and ward costs £73 per day. The disposable 
laparoscopic instruments cost £303 per set, and other laparoscopic equipment 
£60 per operation.
Statistical methods
The trial aimed to recruit 300 patients over two years. Using a significance 
level of five per cent, such a sample would have 80 per cent power to detect 
differences between laparoscopic and minilaparotomy groups greater than one 
third of the standard deviation of normally distributed outcome measures 219. 
For the end-points of post-operative pain and pulmonary function, the study
TOTAL THEATRE COSTS FOR YEAR 
THEATRE COSTS _ _____________________________________
PER MINUTE THEATRE TIME (minutes) UTILIZED
IN FINANCIAL YEAR
, „ . OPERATION TIME
SURGEON’S COSTS _ (ANNUAL SALARY +
IN THEATRE EMPLOYER’S COSTS) (Time Worked in the Year
i.e. 46 weeks x 40 hours)
ANNUAL COST FOR WARD
WARD COSTS = ----------------------------------------------
TOTAL BEDSTAY DAYS UTILIZED
JUNIOR HOUSE OFFICER 
COST FOR WARD COVER 
PER BEDSTAY DAY
SENIOR HOUSE OFFICER 
COST FOR WARD COVER 
PER BEDSTAY DAY
(SALARY + EMPLOYER’S COSTS) 
OF ALL RESIDENTS
ANNUAL BEDSTAY DAYS
(SALARY + EMPLOYER’S COSTS)
10% O F ----------------------------------------------------
ANNUAL BEDSTAY DAYS
CONSULTANT SURGEON _  _  (SALARY + EMPLOYER’S COSTS)
COST FOR WARD COVER = 5 %  0 F  AKTMTTAT d u h c t a v  d a v c  
PER BEDSTAY DAY ANNUAL BEDSTAY DAYS
LAPAROSCOPIC 
EQUIPMENT COST 
PER OPERATION
TOTAL COST OF , CAPITAL INTEREST 
EQUIPMENT OVER PERIOD OF USE
NUMBER OF OPERATIONS 
PER YEAR X 5 YEARS
£25,000+ £5,000 
100X 5
=  £60
FIGURE 3.3 Formulae for calculating theatre, ward and 
laparoscopic equipment costs.
W estern Infirm ary Royal Infirm ary
THEATRE COSTS 
Theatre Nursing Staff 
Anaesthetists 
Theatre Pharmacy 
Theatre Other 
Theatre Subtotal 
Consultant Surgeon 
Senior Surgical Registrar 
Surgical Senior House Officer
Total Theatre Costs
WARD COSTS 
Ward
Consultant Surgeon 
Senior Surgical Registrar 
Senior Surgical House Officer 
Junior Surgical House Qffficer
Total W ard Costs
INVESTIGATIONS
Chest Xray
Electrocardiogram
Pathology
Bacteriology
Full blood count
Blood Grouping
Biochemistry
£/minute £/minute
1.52 n/a
2.22 n/a
0.93 n/a
0.44 n/a
5.11 4.67
0.53 0.53
0.41 0.41
0.31 0.31
6.37 5.92
£/patient/day £/patient/day
67.94 66.33
0.81 0.81
0.62 0.62
0.47 0.47
4.08 4.08
73.92 72.31
£/test £/test
11.75 16.87
5.60 5.00
39.00 67.38
21.45 8.85
2.51 1.45
11.58 11.58
2.46 0.34
TABLE 3.1 A breakdown of costings from resource 
management units at the Western and Royal 
Infirmaries, Glasgow.
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aimed to detect differences greater than one half of the standard deviation. To 
yield 80 per cent power to detect such differences at a significance level of five 
per cent, a sample of 120 patients was needed 279 Hence, post-operative pain 
and pulmonary function were measured only for the first year of the trial - from 
September 1991 until August 1992.
The trial was pragmatic, i.e. designed to reflect normal clinical practice 280. In 
particular, results were analysed by intention to treat, so that patients from 
both groups requiring conversion to standard cholecystectomy were 
included. A secondary analysis was performed, after excluding patients 
requiring conversion to standard cholecystectomy and patients with 
complications which prolonged hospital stay.
Normally distributed data were analysed by the t test, while those not 
normally distributed were analysed by the Mann-Whitney U test. Categorical 
data were analysed by the chi-squared test. Ordinal pain scores and patients' 
ratings of outcome were analysed by the chi-squared test for linear trend. An 
analysis of covariance was performed when, despite randomisation, thee was 
any imbalance in baseline variables between the two groups.
3.3 RESULTS
Informed consent to randomisation was sought from 311 patients eligible for 
the trial. Nine refused randomisation, leaving 302 who were randomised. Of 
these, three did not undergo cholecystectomy and were therefore excluded 
from analysis; two were unexpectedly found to have liver metastases from an 
unknown primary, and another found to have severe cirrhosis.
Randomisation produced two groups with similar pre-operative characteristics 
(Table 3.2).
Of the patients randomised to laparoscopic cholecystectomy, 15 (10%) 
required conversion to open cholecystectomy; the reasons were severe 
cholecystitis or chronic empyema in seven, unclear anatomy in three, dense 
intrabdominal adhesions in two, bleeding in one, equipment failure in one, and 
bile duct stones in one. In the minilaparotomy group, the median incision 
length was 7 cm (interquartile range 5-9cm). An incision greater than 10cm 
was necessary in 14 patients (10%); the reasons were severe cholecystitis or 
empyema in four, morbid obesity in four, bile duct stones in two, bleeding in 
two, cholecysto-choledochal fistula in one, and an intrahepatic gallbladder in 
one. Complications of cholelithiasis (mucocoele or chronic empyema) were 
found in 43 (14%) of 299 patients (Table 3.2). One elderly minilaparotomy 
patient with a large cholecystoduodenal fistula was treated by 
cholecystostomy and stone removal alone.
The mean (SD) operation time was significantly shorter in the minilaparotomy 
group (57 (24) minutes versus 71 (20); t test - p<0.001) - Figure 3.4. The 
median (interquartile range) postoperative hospital stay of two (2-4) days after 
laparoscopic cholecystectomy was significantly shorter than that of four (3-5) 
days after minilaparotomy (Mann-Whitney U test - p<0.001) - Figure 3.5.
Minilaparotomy
group
(n=148)
Laparoscopic
group
(n=151)
Median (IQR) age (yrs) 52 (41-63) 54 (41-64)
Sex (% female) 84% 88%
Mean height [cm] (SD) 161 (8) 162 (8)
Mean weight [kgs] (SD) 67 (13) 70 (13)
Mean body mass index 26.1 (4.8) 26.7 (4.8)
[kg/m*] (SD)
Median (IQR) duration of 11 (6-24) 10 (6-24)
symptoms (months)
No. of patients (%): No. of patients (%):
Indication:
Biliary colic 91 (61%) 103 (68%)
Previous acute cholecystitis 36 (24%) 36 (24%)
Gallstone pancreatitis 10 (7%) 9 (6%)
Previous choledocholithiasis 11 (7%) 3 (2%)
ASA class 1 66 (45%) 66 (44%)
class 2 51 (34%) 61 (40%)
class 3 25 (17%) 19 (13%)
class 4 6 (4%) 5 (3%)
Employment status:
Housewife 46 (31%) 54 (36%)
Retired 41 (28%) 45 (30%)
Full-time paid employment 33 (22%) 29 (19%)
Part-time paid employment 14 (9%) 14 (9%)
Unemployed 10 (7%) 7 (5%)
Other 4 (3%) 2 (1%)
Complicated operative findings:
Chronic empyema 12 (8%) 14 (9%)
Mucocoele (No. of patients (%)) 6 (4%) 11 (7%)
Cholecysto-choledochal fistula 1 (1%) 0 (0%)
Cholecysto-duodenal fistula 1 (1%) 0 (0%)
ASA = American Society of Anaesthesiologist's physical fitness classification 
IQR=interquartile range.
TABLE 3.2 Patient characteristics of all patients in the trial.
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FIGURE 3.4 Operation time in the two groups
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FIGURE 3.5 Post-operative hospital stay in the two groups
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In the first year of the randomised trial during which post-operative pain and 
pulmonary function were assessed, a total of 131 patients were randomised, 65 
to minilaparotomy cholecystectomy and 67 to laparoscopic cholecystectomy. 
The two group of patients evaluated for postoperative pain and pulmonary 
function were well matched for age, sex, body mass index, American Society 
of Anaesthesiologists (ASA) class 281, indication for operation, and pre­
operative pulmonary function but less well matched for smoking (Table 3.3).
Pain and analgesia consumption
The amount of morphine used in the peri-operative period was similar in both 
groups (Table 3.4). Patients in the minilaparotomy group had experienced 
significantly more pain than those in the laparoscopic group at both 24 and 
48 hours, as measured by linear analogue and ordinal pain scores (Table 3.5 
and Figure 3.6). Patient-controlled morphine consumption was also 
significantly greater in the minilaparotomy group over both the first and 
second periods of 24 hours (Table 3.6. and Figure 3.7). Pain referred to the 
shoulder was experienced postoperatively by 8 (13%) minilaparotomy 
patients compared with 15 (23%) laparoscopic patients (x2=2.2, 1 d.f., 
p=0.14).
Pulmonary function
In both groups, there was a postoperative fall in all three measures of 
pulmonary function, most marked at 24 hours, with some improvement at 48 
hours. The fall in pulmonary function was significantly greater in the 
minilaparotomy group at both 24 and 48 hours (Table 3.7 and Figure 3.8). 
Average oxygen saturation over the first 16 postoperative hours was 
significantly higher in the laparoscopic patients (Table 3.8 and Figure 3.9). 
Furthermore, oxygen saturation fell below 86% in a greater proportion of the 
mini laparotomy patients.
Minilaparotomy
group
(n=65)
Laparoscopic
group
(n=67)
Mean Age (range) 53 (19-82) 54 (23-80)
Number of Males 12 (18%) 11 (16%)
Mean Height [cm] (S.D.) 160(8.1) 162 (8.2)
Mean Weight [kgs] (S.D.) 67(15.1) 71 (14.6)
Mean Body Mass Index 26 (5.1) 27 (5.3)
[kg/m2] (S.D.)
Number of Smokers 33 (51%) 23 (34%)
ASA class 1 28 21
class 2 23 29
class 3 11 13
class 4 3 4
Indication :
Biliary Colic 44 42
Acute Cholecystitis 17 19
Gallstone Pancreatitis 4 6
MeanFVC [litres] (S.D.) 2.80 (0.74) 2.94 (0.77)
Mean FEVi [litres] (S.D.) 2.26 (0.70) 2.42 (0.69)
Mean PEFR [ml/sec] (S.D.) 360(117) 385 (108)
ASA = American Society of Anaesthesiologist's physical fitness classification.
TABLE 3.3 Preoperative characteristics of patients randomised 
over the first year of the trial and in whom 
postoperative pain and pulmonary function was 
assessed.
Minilaparotomy Laparoscopic Statistic
group 
(n=58 )
group
(n=59)
No of patients (%) given 
opiate premedication
26 (45%) 29 (49%) *2=0.2,1 d.f., 
p=0.64
Median intra-operative 
morphine dose [mg] 
(median/interquartile range)
5 (3-10) 5 (2.5-10) p=0.98 (U test)
No of patients (%) requiring 
bolus of morphine in recovery
11 (19%) 8 (14%) *2=0.6,1 d.f., 
p=0.43
TABLE 3.4 Peri-operative morphine administration in the
laparoscopic and minilaparotomy groups.
Minilaparotomy Laparoscopic 
group group 
(n=64) (n=65)
95% confidence 
interval for the 
difference in the 
medians
Linear Analogue Pain Score
median (IQR) [mm]:
24 hours 59 (40-79) 40 (25-54) 10-26***
48 hours 43 (24-64) 21 (10-39) 11-28***
Ordinal Pain Score 
(number of patients):
24 hours: None 0 5
Mild 9 16
Moderate 18 29
Severe 37 15###
48 hours: None 3 18
Mild 15 24
Moderate 30 17
Severe 16 5###
*** Mann-Whitney U test pcO.OOl
### Chi-squared Test for Linear Trend pcO.OOl
IQR=interquartile range
TABLE 3.5 Postoperative linear analogue and ordinal pain 
scores in the two groups.
Minilaparotomy Laparoscopic 
group group 
(n=64) (n=65)
95% confidence 
interval for the 
difference in the 
medians
Median (interquartile range) [mg]
1st 24 hours 40 (35-47) 22 (20-30) 
2nd 24 hours 11 (0-31) 0 (0-20)
8-22***
0-10**
Mann-Whitney U test *** pcO.OOl **p<0.01
TABLE 3.6 Patient-controlled morphine consumption over the 
first two postoperative days in the two groups.
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FIGURE 3.7 Post-operative Morphine Consumption
Minilaparotomy Laparoscopic 95% confidence 
group (n=64) group (n=64) interval for the 
_______________________________  difference in
Mean percentage of pre-operative the means 
value (S.D.)
FVC 24 hours 54(16) 65(19) 4_ ^ 7***
48 hours 66(16) 76(17) 4-16***
FEVi 24 hours 54(17) 64(17) 4-16**
48 hours. 65 (17) 75(18) 4-16**
PEFR 24 hours 49(16) 64(20) 9-22***
48 hours 58 (19) 75(23) 10-25***
FVC = forced vital capacity FEV1 = forced expiratory volume in one second 
PEFR = peak expiratory flow rate 
Student's t test: *** pcO.OOl ** pcO.Ol
TABLE 3.7 Pulmonary function on the first two postoperative 
days in the two groups.
Minilaparotomy Laparoscopic 95% confidence 
group group interval for the
(n=58) (n=56) difference
Oxygen saturation 91.2(3.3) 92.9(2.7) 0.4-2.6**
Mean (S.D.) [%]
Number of patients (%)
whose oxygen saturation 30 (52%) 15 (27%) 8-42 %##
fell below 86%
Student’s t test: ** p<0.01 Chi-squared test: ## p<0.01
TABLE 3.8 Average oxygen saturation over the first 16 post­
operative hours in the two groups
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Although there was a difference in the proportion of smokers in the two 
groups, it did not achieve statistical significance. Nevertheless, the effect of 
smoking on postoperative pulmonary function and oxygen saturation was 
examined. There was no significant difference between smokers and non- 
smokers in postoperative pulmonary function but, oxygen saturation was 
significantly lower in smokers. After taking the effect of smoking into 
account, the difference in oxygen saturation between the two groups 
remained significant; the adjusted mean oxygen saturation was 92.8% in the 
laparoscopic group, and 91.3 in the minilaparotomy group (p=0.003).
Although the main analysis of post-operative pain and pulmonary function 
was by "intention to treat", a secondary analysis was also carried out from 
which the nine minilaparotomy patients who required an incision greater than 
10cm, and the nine laparoscopic patients who required conversion to open 
cholecystectomy were excluded. As in the main analysis, all outcome 
measures were significantly better in the laparoscopic group. Mean linear 
analogue pain score, mean oxygen saturation and median morphine 
consumption in both groups were almost identical with those in the main 
analysis, while mean pulmonary function was 1% higher in the minilaparotomy 
group, and 2% higher in the laparoscopic group.
Complications
The incidence of both major and minor complications was similar in both 
groups (Table 3.9).
In the minilaparotomy group two minor bile duct injuries occurred. In the first, 
a 3 mm transverse incision was made in the common hepatic duct; this injury 
was immediately repaired with two interrupted sutures. In the second, a 
similar injury occurred at the junction of the cystic and common bile ducts; 
this was managed by inserting a T tube at the site of injury. Both patients
Complication
Minilaparotomy
(n=148)
No. (%)
Laparoscopic
(n=151)
No. (%)
Wound infection 11 (7.4) 13 (8.6)
Wound haematoma 0 (0) 3 (1.3)
Urinary retention 6 (4.1) 2 (13)
Minor chest infection 5 (3.4) 1 (0.7)
Post-operative haemorrhage 3 (3.0) 3 (2.0)
Urinary tract infection 2 (1.4) 0 (0)
Septicaemic shock 1 (0.7) 0 (0)
Adhesive obstruction 1 (0.7) 0 (0)
Retained bile duct stone 0 (0) 1 (0.7)
Major bile duct injury 0 (0) 1 (0.7)
Minor bile duct injury 2 (1.4) 0 (0)
Cystic duct bile leak 0 (0) 1 (0.7)
Subvesical bile duct leak 1 (0.7) 2 (1.4)
Readmission 3 (2.0) 5 (3.3)
Total number of patients 
with complications
30 (20%) 26 (17%)
TABLE 3.9 Postoperative complications.
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remain well one year later. Percutaneous ultrasound drainage was required in 
a minilaparotomy patient for a subvesical bile duct leak demonstrated by 
endoscopic retrograde cholangiography (ERCP). One patient developed 
septicaemic shock post-operatively and had a negative re-laparotomy. Three 
patients required transfusion post-operatively for bleeding. Re-operation was 
required in one patient for adhesive obstruction at one month. There was one 
death from myocardial infarction in a minilaparotomy patient on the second 
post-operative day.
In the laparoscopic group, a patient presented with jaundice one week after 
cholecystectomy, and ERCP demonstrated complete division and clipping of 
the common hepatic duct; this was repaired by primary anastamosis over a T 
tube, and after six months follow-up the patient remains well. A laparoscopic 
patient developed a bile leak and jaundice post-operatively: the bile collection 
was drained percutaneously, and ERCP revealed a subvesical bile duct leak 
and a stone in the common bile duct, which was removed endoscopically. A 
laparoscopic patient who developed biliary peritonitis two weeks 
postoperatively from a subvesical bile duct leak required laparotomy and 
drainage. A cystic bile duct leak in a laparoscopic patient was treated by 
percutaneous drainage and endoscopic placement of a biliary stent. Three 
patients required transfusion post-operatively for bleeding.
Patient questionnaires
The response rate to the one, four, and twelve week questionnaires was 78%, 
88%, and 81% respectively in both groups. The times to return to normal 
activities after surgery are shown in Table 3.10. Laparoscopic patients 
returned more quickly to hobbies, work in the home (Figure 3.10 and social 
activities, but there was no difference in the time to return to sexual activity or 
paid employment.
Minilaparotomy Laparoscopic Significance
median (IQR) n median (IQR) n level (U test)
Hobbies 12 (7-21) 118 7 (4-14) 128 0.0014
Work in the home 15 (10-24) 114 10 (5-19) 122 <0.001
Social activities 21(11-28) 111 14 (7-21) 125 <0.001
Sexual activity 21 (12-28) 64 21 (11-24) 60 0.33
Paid employment 41 (21-60) 37 36 (28-60) 31 0.86
IQR = interquartile range
TABLE 3.10 Time (days) to return to normal activities after
cholecystectomy.
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Figure 3.10: Time to return to work in the home after 
cholecystectomy
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In general, the SF-36 and HADS scores improved from the first to the twelfth 
postoperative week (Table 3.11). One week after surgery laparoscopic 
patients had significantly better perceived health, better physical and social 
functioning, less role limitation due to physical problems, less pain (Figure 
3.11), and less depression than minilaparotomy patients. (Although 
median/IQR social functioning scores were the same in both groups at one 
week, the mean (SD) was significantly higher in the laparoscopic group: 74 
(29) versus 67 (30)). At four weeks, laparoscopic patients still had better 
physical functioning and less depression, but by twelve weeks there were no 
significant differences between the groups in any of the patient-reported 
scores.
Patients' ratings of outcome after cholecystectomy is shown in Table 3.12.
At twelve weeks, the majority of patients (minilaparotomy 93%, laparoscopic 
group 92%) thought the outcome of their operation was "good" or 
"excellent". Nevertheless, at one week, laparoscopic patients were 
significantly more satisfied with the outcome of their operation than patients 
in the minilaparotomy group, with a tendency to greater satisfaction at four 
and twelve weeks also. Similarly, although more than 95% of patients in both 
groups were satisfied with the appearance of their scar, laparoscopic patients 
were significantly more satisfied at four and twelve weeks with a tendency to 
greater satisfaction at one week also. At three months, 97% of laparoscopic 
patients would recommend the operation they had had to somebody with the 
same gallbladder problem compared with 94% in the minilaparotomy group.
Cost
Theatre costs were higher for laparoscopic cholecystectomy because of longer 
theatre time, and higher equipment costs, including disposable instruments 
(Table 3.12). Ward costs were higher for minilaparotomy because of longer 
hospital stay. The mean total cost per patient was £396 greater for the
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Minilaparotomy 
mean (SD)
Laparoscopic 
mean (SD)
t test: 
p value
Theatre £577 (149) £687 (126) <0.001
Laparoscopic disposables - £303
Laparoscopic equipment - £60
Ward costs £393 (190) £299 (168) <0.001
Pathology/Bacteriology £87 £87
ECG & Chest Xray £15(8) £15(8)
Additional (complications) £17 (94) £35 (176) 0.28
TOTAL 
(excluding disposables)
£1090 (296) £1183 (296) 0.008
TOTAL
(including disposables)
£1090 (296) £1486 (296) <0.001
ECG = electrocardiogram
TABLE 3.13 Cost per patient for cholecystectomy.
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laparoscopic method (95 % Cl £328 to £465). However, if disposable 
instruments had not been used, the difference in mean cost would have been 
only £93 (95% Cl £ 25 to £162).
Secondary analysis
Although the main analysis was by "intention to treat", we also carried out a 
secondary analysis from which minilaparotomy patients who required an 
incision greater than 10cm, laparoscopic patients who required conversion to 
open cholecystectomy, and patients with a complication prolonging hospital 
stay were excluded, leaving 120 in the minilaparotomy group, and 131 in the 
laparoscopic group. Median postoperative stay was two days (interquartile 
range 2-3) in the laparoscopic group compared to three (interquartile range 3- 
4) in the minilaparotomy group (Mann-Whitney U test p<0.001).
Nonrandomised patients
During the study period, 42 patients who did not fit the study criteria required 
cholecystectomy . The reasons for exclusion were common bile duct stones in 
15, perforated gallbladder empyema in 5, gallbladder empyema in 6, acute 
cholecystitis requiring urgent surgery in 6, severe upper abdominal adhesions 
in 3, and similtaneous operative procedure in 7. Three of these were found to 
have a cholecystocholedochal fistula. Major complications in these patients 
were retained bile duct stone (1), bile leak from a choledochoduodenostomy 
(1), subhepatic abscess (1), and pulmonary embolism (1). One patients who 
presented with cholangitis, septic shock and respiratory failure died from 
multi-organ failure. There were also 9 patients eligible for the study who 
refused consent. All of these patients underwent laparoscopic 
cholecystectomy without complication.
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3.4 DISCUSSION
This is the first randomised trial to compare laparoscopic and minilaparotomy 
cholecystectomy with a sample size of over a hundred patients and to use 
objective assessment of pain with patient-controlled delivery of analgesia.
The findings demonstrate a significant advantage for laparoscopic 
cholecystectomy in terms of postoperative pain, pulmonary function, hospital 
stay and return to normal activity. Although the laparoscopic operation 
resulted in less postoperative pain than minilaparotomy cholecystectomy, 15 
(23%) of 65 laparoscopic patients complained of severe pain, and 14 used 
more than 40 mg of morphine in the first 24 hours. A significant reduction in 
pulmonary function also occurred after laparoscopic cholecystectomy - more 
than a third in all three measures on the first postoperative day.
Postoperative oxygen desaturation may be due to a number of different 
mechanisms: hypoventilation 193, obstructive sleep apnoea 194 (both of 
which may induced by anaesthetic agents or opiates), or intrapulmonary 
shunting from small airway closure 192. In the present study, it is not clear 
which of these factors resulted in the lower oxygen saturation levels and the 
higher incidence of desaturation in the minilaparotomy group, but it was 
probably a combination of all three factors. Morphine consumption in the 
minilaparotomy group was twice that in the laparoscopic group; this is likely 
to have contributed to a higher incidence of episodes of obstructive apnoea, 
and respiratory depression. The greater reduction in postoperative pulmonary 
function in the minilaparotomy group is likely to have been associated with 
more small airway collapse and therefore increased intrapulmonary shunting.
There has been only one other randomised trial of laparoscopic versus 
minilaparotomy cholecystectomy reported in the English literature 99 
However, the small sample size (62 patients), loss to follow-up (only 36
patients completed questionnaires) and difficulties with randomisation limit 
the value of this Canadian study 232,233 There were no significant 
differences between the groups in the patient-assessed outcome measures 
(McGill pain scores, the Nottingham Health Profile, a quality of life index, and 
a visual analogue scale) but this may have been entirely due to the small 
number of patients; in particular, the laparoscopic group did report earlier 
improvements in quality of life, even though the difference was not 
statistically significant. These results accord with those of the present study, 
in which laparoscopic patients reported significantly better SF-36 and HADS 
scores at one week, smaller inter-group differences at one month, and no 
differences by three months. In the Canadian study, the modest advantage of 
the laparoscopic method over minilaparotomy in hospital stay (median 3 
versus 4 days ) and duration of convalescence (median 8 versus 13 days) was 
also consistent with the findings of the present study.
The median hospital stay for laparoscopic cholecystectomy in our study is 
similar to that reported from other European centres 32,77,145? whereas a 
median stay of one day is more typical for American centres 76,81 While 
outpatient open cholecystectomy has been reported 4,207^  the median 
postoperative stay of four days after minilaparotomy cholecystectomy in this 
study is comparable with that reported in several studies 6,60,98,99 The 
average postoperative stay for standard cholecystectomy has been falling 
over the past decade and in audit reports from Britain 204 ancj America 95 is 
now six and four days respectively.
The period taken to return to normal activities after laparoscopic 
cholecystectomy in this study was between one and two weeks - similar to 
that widely reported 77,101,114,282 Return to normal activity for open 
cholecystectomy has not been accurately measured but is commonly 
perceived to be at least six weeks 2051 jn this study, patients returned to
normal activites between 10 days and three weeks after minilaparotomy 
cholecystectomy. Less than a third of patients were in paid employment, 
about a third worked in the home, and another third were retired. There was a 
marked discrepancy between the median time to return to work in the home 
(10 days for laparoscopy, and 15 days for minilaparotomy) and the median of 
five to six weeks to return to paid employment. This probably reflects general 
practitioners' and patients' pre-conceived ideas about the appropriate duration 
of convalescence after surgery.
The laparoscopic conversion rate in this study was higher than in reports from 
specialist centres 77, but less than than the 14% reported in a large prospective 
audit in the UK 135. This conversion rate reflected three factors: the severity 
of biliary disease, a low threshold for conversion, and the fact that some 
surgeons were still on the "learning curve".
In this study, minilaparotomy was significantly cheaper than laparoscopic 
cholecystectomy, and would still have been cheaper if reusable instruments 
had been used for laparoscopic surgery. There are conflicting reports on the 
comparative cost of laparoscopic and open cholecystectomy: several studies 
have reported that the costs of laparoscopic cholecystectomy are less than 
open cholecystectomy 101,125,213,283  ^ while one has reported increased costs 
205. Operation time and hospital stay, which are the two main determinants of 
the cost of cholecystectomy, vary from centre to centre. Another important 
factor is whether disposable instruments are used during laparoscopic 
cholecystectomy, re-usable instruments being substantially cheaper.
This study has shown a similar incidence of complications after both 
procedures. However, the low incidence of major complications means that 
only rigorous large scale audit can accurately estimate the incidence of 
iatrogenic complications. Audit has shown a higher incidence of bile duct
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injury after laparoscopic cholecystectomy 134-136 compared with open 
cholecystecytomy 78,90,93,95. Furthermore, the bile duct injuries from 
laparoscopic cholecystectomy tend to be more extensive and higher in the 
duct system 107-109 than those from open cholecystectomy, thus reducing the 
chance of a successful outcome to reconstruction 86. As most studies of 
minilaparotomy have been small, it is unclear whether the minilaparotomy 
technique also results in a higher bile duct injury rate. However, in the 
published results of over 2500 operations there have been only two bile duct 
injuries 1_7. The two injuries occurring during our trial were both minor, and 
did not cause significant morbidity to the patient.
In conclusion, this study has shown that laparoscopic cholecystectomy 
confers moderate benefits on patients in comparison with mini laparotomy 
cholecystectomy. These benefits take the form of reduced postoperative pain 
and pulmonary dysfunction, shorter hospital stay, and earlier return to normal 
activity. However, the laparoscopic operation was more expensive to the 
National Health Service (NHS). It seems likely that, as surgeons complete the 
learning curve, the relative benefit to patients will increase, while the relative 
cost to the NHS will decrease. Rigorous large-scale audit is needed to ensure 
that the apparent superiority of laparoscopic cholecystectomy is maintained in 
the long term.
Chapter 4
METABOLIC RESPONSES TO 
LAPAROSCOPIC AND 
MINILAPAROTOMY 
CHOLECYSTECTOMY
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4.1 INTRODUCTION
The stress of surgery evokes a wide variety of biochemical and physiological 
changes including production of cytokines and acute phase proteins, increase 
in the levels of "stress" hormones, loss of muscle protein, increased vascular 
permeability, and changes in white cell count subsets. Although some of 
these responses are considered to be a homeostatic defence mechanism, some 
of the consequences, such as the catabolic state, are thought to be deleterious 
24 *. Hence, in recent years, many investigators have sought to find ways of 
reducing the metabolic response to surgery 239,240,284-286
With reference to cholecystectomy, attempts have also been made to reduce 
the degree of surgical trauma. Indeed, the use of a small transverse incision for 
open cholecystectomy (minilaparotomy) has been shown to result in a more 
rapid postoperative recovery than a standard incision 1-7 More recently, 
laparoscopic cholecystectomy has been introduced rapidly into routine 
clinical practice, and is replacing open cholecystectomy as the procedure of 
choice for symptomatic cholelithiasis 124 The claimed advantages are less 
postoperative pain 203, and a more rapid return to normal activity 124
It has been shown that the magnitude of the metabolic response to injury is 
proportional to the degree of the surgical trauma 8_11. It has been postulated, 
therefore, that the reduction of "access trauma" by the laparoscopic technique 
might diminish the metabolic response to cholecystectomy 145. However, 
diagnostic laparoscopy alone is associated with a substantial hormonal and 
glycaemic response, which is thought to be evoked by the stimulus of 
peritoneal distension 246. Furthermore, the magnitude of the metabolic 
response has been shown to correlate with the duration of surgery 9»287 
which, for laparoscopic cholecystectomy, is longer than open 
cholecystectomy 81.
Therefore, the aim of this randomised study was to compare both the pattern 
and the magnitude of the metabolic response to injury after laparoscopic and 
minilaparotomy cholecystectomy.
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4.2 PATIENTS AND METHODS
This study was carried out as part of the randomised controlled trial comparing 
minilaparotomy and laparoscopic cholecystectomy described in Chapter 3.
The metabolic study was approved by the local hospital ethical committees 
and informed consent obtained from all patients. Detailed metabolic studies 
were performed in ten consecutive patients in each arm of the trial. In the 
metabolic study, patients requiring conversion to standard cholecystectomy, 
patients with medical conditions or on treatment that might result in an altered 
metabolic response to surgery, and patients who developed complications 
were excluded. The median age (range) in the laparoscopic group was 58 
(30-71) years and 44 (25-70) in the minilaparotomy group. There was one 
male in each group.
Anaesthetic techniques were similar in both groups. Agents used were 
thiopentone or propofol for induction, suxamethonium for initial muscle 
relaxation, morphine and ethrane for maintenance, atrocurium besylate or 
vecuronium for muscle relaxation, and neostigmine bromide for reversal. 
Minilaparotomy cholecystectomy was performed through a five to seven 
centimetre subcostal incision 5, while laparoscopic cholecystectomy was 
performed using a four trocar technique using electrocautery. All wounds in 
both groups were infiltrated with 20mls of 0.5% bupivacaine at the end of the 
procedure. The median operation time was longer in the laparoscopic group 
(median 65 versus 46 minutes, p=0.01). Postoperatively, patients received 
morphine by a disposable patient-controlled analgesia device 272. Over the 
first 24 hours, patients were given intravenous fluids (1 litre normal saline, and 
2 litres 5% dextrose), with nil orally, and thereafter allowed free fluids and a 
normal diet. All patients made an uneventful postoperative recovery.
A blood sample was collected from an indwelling venous cannula on the 
morning of surgery (before premedication), and at 3 ,6 ,9 ,1 2 , 18,24,48, 72, and
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168 hours after incision. Blood samples were immediately separated by 
centrifugation, and aliquots of serum and plasma frozen and stored at -20°C. 
Twenty-four hour urine samples were collected the day before surgery, and 
over the first, second and third postoperative days. An additional urine 
sample was collected on the 7th postoperative day. Samples were preserved 
with thymol, and after recording volumes, aliquots frozen and stored at -20°C.
The cytokine, interleukin-6 (IL-6), which is thought to play a central role in 
the development of the metabolic response 116, was measured by the 
hybridoma growth stimulation assay using the mouse B-cell hybridoma 7TD1 
line 9,237,288 c eu numbers were evaluated colorimetrically using 3-(4,5,- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Thiazolyl B lue)289 a 
tetrazolium salt cleaved by dehydrogenase enzymes present in living cells. 
Standardization was performed using recombinant IL-6 290 (obtained from the 
National Institute of Biomedical Standards and Controls, Potters Bar, 
Hertfordshire, UK). Serum samples were heat-treated at 56°C for 30 minutes 
before analysis to inactivate any inhibitors. The detection limit of this 
bioassay was approximately 14 units/ml, and the imprecision (co-efficient of 
variation) calculated from 20 consecutive assays was 19%. The specificity of 
the assay was confirmed using a polyclonal anti-IL-6 antibody.
The positive acute phase proteins, C reactive protein (CRP) and fibrinogen, 
and the negative acute phase proteins, albumin and transferrin (whose fall 
reflects increased vascular permeability and loss to the tissue spaces 242), 
were measured by nephelometry. The detection limit for serum CRP was 5 
mg/1. Serum iron, which falls after surgery 291, was measured colorimetrically 
using a Hitachi 737 analyser (Boehringer, Mannheim, Germany).
Neutrophil and lymphocyte counts were measured with a Coulter Blood 
Analyser. Plasma cross-linked fibrin degradation products (FDPs), a measure 
of fibrin turnover, were measured using an enzyme linked immuno-absorbancy
88
assay (AGEN, Parsippany, New Jersey, USA). The "stress" hormone, cortisol, 
was measured by fluorescence polarization immunoassay. Polymorphonuclear 
(PMN) elastase, which is released by activated neutrophils 292, was measured 
using the PMN elastase IMAC immuno-activation kit (Diagnostica Merk, 
Frankfurt, Germany).
Urinary 3-methylhistidine, which is a measure of muscle protein breakdown 
293, was measured by ion-exchange chromatography with ninhydrin 
detection. Urinary creatinine was measured using the alkaline picrate reaction 
and urea measured electrochemically using a Beckman CX-3 instrument. 
Urinary nitrogen was calculated on the basis that urea loss comprises 80 per 
cent of total nitrogen loss.
Unlike methylhistidine and urea, urinary samples for catecholemine 
measurement required to be acidified. Therefore, 24 hour urine collections 
(acidified with 20mls of concentrated hydrochloric acid) for catecholamine 
measurement were collected from a second group of 20 patients, 10 in each 
arm of the study. In this group of patients, the median age (range) was 
56 (27-72) in the laparoscopic group, and 45 (19-82) in the minilaparotomy 
group with no males in the laparoscopic group and two in the minilaparotomy 
group. Urinary catecholamines were measured using high performance liquid 
chromatography with electrochemical detection 294.
As part of the study of postoperative pain and pulmonary function described 
in Chapter 3, peak expiratory flow rate was measured the day before 
operation and 24 hours postoperatively using a Respiradyne pulmonary 
function monitor (Sherwood Medical, Crawley, W. Sussex, UK). Analgesia 
consumption over the first 24 hours was assessed using patient-controlled 
delivery of morphine (Baxter PCA infusor system, Baxter Healthcare Ltd, 
Norfolk, UK), and pain assessed by a linear analogue pain score at 24 hours.
Statistics
In order to produce summary measures 295, each parameter was plotted 
against time and the area under the curve calculated for each individual 
patient using the programme, Multifit, on an Apple Macintosh computer. For 
the two negative acute phase reactants, albumin and transferrin, the falls from 
pre-operative values were plotted. Areas under the curve in the two groups 
were compared using the Mann-Whitney U test. The magnitude of changes in 
each metabolic variable (areas under the curve) were compared using 
Pearson's correlation. Values of white cell counts, urinary nitrogen, 
3-methylhistidine and catecholamines in the two groups were compared at 
each time point with the Mann-Whitney U test (with the Bonferroni 
correction as appropriate). Comparison of postoperative and pre-operative 
catecholamines and 3-methylhistidine was performed with the Wilcoxon 
matched pairs test (with the Bonferroni correction).
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4.3 RESULTS
The time course of the metabolic changes is shown in Figures 4.1-4.9 and 
Table 4.1. IL-6 rose within 3 hours, peaking at 6 hours, with levels only 
beginning to fall after 24 hours, and returning to near normal levels at 7 days 
(Figure 4.1). CRP began to rise after 9 hours, peaking at 48 hours, and 
returning to near normal levels at 7 days (Figure 4.2). Albumin and transferrin 
fell over the first 24 hours, remaining depressed over the first 3 days, but rising 
by day 7 (Figures 4..3 and 4.4). The iron/transferrin ratio fell within 6 hours 
and remained depressed at 7 days (Figure 4.5). Fibrinogen and FDPs rose 
steadily over the first 3 days, remaining elevated at 7 days (Figures 4.6 and 
4.7). Cortisol levels were elevated pre-operatively reflecting anxiety, and rose 
to peak levels at 3-9 hours, returning to normal by 24 hours (4.8). Neutrophil 
counts were elevated at 6 hours, slightly raised at 48 hours, and near normal at 
7 days (Table 4.1). PMN elastase was elevated modestly at all postoperative 
time points, compared to pre-operative values (Wilcoxon matched pairs test 
p<0.01) - Figure 4.9. Lymphocyte counts were depressed at 6 and 48 hours, 
and returned to near base-line values at 7 days (Table 4.1). A similar time 
course of metabolic changes occurred in the two groups.
The calculated areas under the curves are shown in Table 4.2. Although there 
were considerable within group variations, there were no significant 
differences in the magnitude of the changes between the two groups. By 
contrast, the laparoscopic patients had better postoperative pulmonary 
function, consumed less morphine and had lower pain scores than the 
minilaparotomy patients (Table 4.3).
Urinary nitrogen loss was similar in both groups (Table 4.4). Food intake was 
not measured, and nitrogen balance could not therefore be calculated. 
However, both groups started eating on the first postoperative day.
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Morphine Consumption 
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TABLE 4.3 Post-operative pain and pulmonary function 24 
hours after cholecystectomy.
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Postoperative urinary 3-methylhistidine levels did not differ significantly from 
pre-operative values, and were all within the normal range (Table 4.4).
There were no significant inter-group differences in catecholamine levels at 
the three time points (even without Bonferroni correction - Table 4.4). All but 
one noradrenaline value in each group at each time point were below the 
upper reference limit. However, noradrenaline levels on the first and second 
postoperative day were significantly higher than on the pre-operative day 
(first day p=0.04, second day p<0.001). Adrenaline levels on the pre­
operative day were above the upper reference limit in 5 patients in the 
laparoscopic group and 2 in the minilaparotomy group probably reflecting 
anxiety. Postoperative values were not significantly different from pre­
operative values. All urinary dopamine levels were within the normal range 
and postoperative values did not differ significantly from pre-operative values.
There was a significant association between the response areas of several 
metabolic variables, in particular IL-6, CRP and PMN elastase (Table 4.5). 
There was also a strong correlation between the albumin and transferrin fall. 
There was a weak correlation between duration of surgery and IL-6 response 
(r=0.50 p=0.040), but not with CRP response (r=0.36 p=0.15). There was no 
correlation between pain scores and pulmonary function and the metabolic 
variables, but there was a weak correlation between morphine consumption 
and IL-6 and transferrin changes.
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4.4 DISCUSSION
This study has demonstrated a significant metabolic response to both 
laparoscopic and minilaparotomy cholecystectomy, with no significant 
differences between the two types of surgery. By contrast, in Chapter 2 it 
was found that laparoscopic cholecystectomy results in less postoperative 
pain than minilaparotomy cholecystectomy, a smaller reduction in 
postoperative pulmonary function, better postoperative oxygen saturation, 
and a more rapid return to normal activity. Furthermore, in the present study, 
there was no correlation between the more clinical end-points, postoperative 
pain and pulmonary function, and the magnitude of the metabolic response. 
This accords with the finding that elimination of postoperative pain by 
epidural infusion of bupivacaine does not significantly alter the metabolic 
response to cholecystectomy 284,286 Postoperative pain is thus only one of a 
number of factors affecting the magnitude of the metabolic response to 
surgery.
The metabolic response to minilaparotomy cholecystectomy has not been 
previously described. The peak CRP response to minilaparotomy documented 
in this study (CRP at 48 hours mean 122, median 101mg/l) was within the 
range of results reported after standard cholecystectomy (mean 87-210 mg/1) 
9,201,202,237,238,296,297 The IL-6 response to both operations in our study 
was similar to that recently reported after standard cholecystectomy using the 
same bioassay 236 The fall in albumin, transferrin and the iron/transferrin ratio 
was also similar to that previously reported after standard cholecystectomy 298. 
However, the peak cortisol response to both operations in this study 
(835nmol/l) was lower that that reported after standard cholecystectomy in 
several studies (1050-1400) 198,285,286,297
Three recent studies have compared selected aspects of the metabolic 
response to laparoscopic and standard cholecystectomy (using historical 201
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and non-randomised 198,202 controls). The CRP response to laparoscopic 
cholecystectomy reported in two of the studies (CRP at 48 hours mean 21 202 
and 40 201 mg/1) was lower that that found in our study (CRP median 54, 
mean 118 mg/1), and significantly lower than standard cholecystectomy. 
Furthermore, using an immunoradiometric assay, Joris et al. found lower IL-6 
levels after laparoscopic compared to standard cholecystectomy (12 versus 70 
pg/ml), although measurements were made at only three time points and the 
control group was historical 20!.
Two of these three published studies showed a similar cortisol response after 
open and laparoscopic cholecystectomy 198,201. One of the studies reported 
a trend towards lower plasma levels of adrenaline after laparoscopic 
cholecystectomy 20!, while another of these three studies found higher 
urinary catecholamine breakdown products (vanillylmandelic acid) after 
laparoscopic cholecystectomy 202.
In addition to the above mentioned published studies, there have been two 
further studies reported in abstract form comparing the metabolic responses to 
laparoscopic and open cholecystectomy 299300 Both of these found a lower 
CRP response to laparoscopic cholecystectomy, and one found a lower IL-6 
response 300.
A number of the above studies contradict the findings of the present study. In 
particular, four studies reported a reduced CRP response 201,202,299300 an(j 
two studies a reduced IL-6 response 201,300 after laparoscopic compared to 
standard cholecystectomy . A defect of the present study was the small 
number of patients studied, although unlike any of the other studies the 
patients were randomised. It is possible that the lack of a statistically 
significant difference between the CRP and IL-6 responses to the two 
operations was due to a type II statistical error, due to the small number of 
patients studied. There was a trend to lower CRP response in the
laparoscopic group, but the median/range of the IL-6 response was similar in 
both groups. The present study found a very wide variation the magnitude of 
the metabolic response to each operation. Therefore, factors other than the 
method of surgery must have a greater influence in determining the magnitude 
of the metabolic response.
The relationship between the different metabolic changes in this study is 
similar to those previously described. In particular, the sequential time course 
of IL-6 which preceded the rise of C reactive protein and fibrinogen, and the 
strong correlation between these three markers, is consistent with IL-6 being 
the primary stimulus to the acute phase response 116. The author is not aware 
of any previous report of changes in PMN elastase after surgical trauma. 
Values were elevated throughout the postoperative period compared with 
pre-operative levels, but changes were modest compared to those seen in 
severe sepsis 301. While monocytes, endothelial cells and fibroblasts are 
thought to be the major in vivo source of IL-6 , some recent evidence suggests 
that circulating neutrophils contribute significantly to IL-6 production 302. 
The highly significant correlation between changes in IL-6 and PMN elastase 
(which is released by activated neutrophils 292) and the immediate rise in 
PMN elastase, found in this study would be consistent with this hypothesis.
In conclusion, this study demonstrates that the laparoscopic technique does 
not reduce the metabolic response when compared with open surgery using a 
small incision. This contrasts with the clinical benefits of less postoperative 
pain and more rapid recovery after the laparoscopic procedure. These 
findings suggest that factors other than the metabolic response are important 
in determining recovery following surgery.
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Chapter 5
VENTILATORY AND BLOOD GAS 
CHANGES DURING LAPAROSCOPIC AND 
MINILAPAROTOMY CHOLECYSTECOMY
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5.1 INTRODUCTION
Until the advent of extended therapeutic laparoscopic procedures such as 
laparoscopic cholecystectomy, most laparoscopies were brief and performed in 
young, otherwise healthy, gynaecological patients. Ventilatory changes in 
these patients have been extensively studied and found to be clinically 
unimportant 247-250 with the increasing popularity of minimally invasive 
general surgery, many laparoscopic procedures now require long periods of 
peritoneal insufflation, and are often performed on patients who are older and 
have respiratory disease. Two recent studies have suggested that greater 
ventilatory changes occur in these patients
End-tidal CO2 partial pressure (P^coi) monitoring is increasingly used during 
anaesthesia as an indirect measure of arterial CO2 tension (Pacoi), and 
therefore the relationship between these two variables is of considerable 
interest. The arterial to end-tidal P coi difference (P&co2 - P^coi) is 
dependent upon many factors including the relative distribution of ventilation 
and perfusion within the lung, and the functional residual capacity 303. 
During laparoscopic procedures, changes in ventilation and perfusion 
distribution due to basal lung compression might be expected to occur 
because of the pneumoperitoneum. Thus, (Paco2 - P&C02) might be expected 
to change.
The aim of the present study was to assess ventilatory and arterial blood gas 
changes during laparoscopic cholecystectomy (using open cholecystectomy 
as a control group), and to assess the accuracy of capnography in monitoring 
arterial CO2 tension changes.
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5.2 PATIENTS AND METHODS
This study was approved by the local hospital ethics committees. Informed 
consent was obtained from all patients in this study, who were participating in 
the randomised trial comparing laparoscopic cholecystectomy and 
minilaparotomy cholecystectomy as described in Chapter 3. Thirty 
consecutive patients in each arm of the randomised trial were studied. Three 
patients in the laparoscopic group who required early conversion to open 
cholecystectomy were excluded.
Patients underwent general anaesthesia and were paralysed and ventilated. 
Anaesthetic techniques were similar in both groups (agents used were 
thiopentone or propofol for induction, suxamethonium for initial muscle 
relaxation, morphine and ethrane for maintenance, and atracurium besylate or 
vecuronium for muscle relaxation). An Ohmeda OAV 7750 ventilator 
(Ohmeda, Hatfield, Hertfordshire, UK) with a non-rebreathing circuit was used. 
Minute ventilation was recorded by a flow transducer on the expiratory side 
of the circuit. Peak airway pressure was recorded by an aneroid pressure 
gauge in the ventilator. End-tidal CO2 tension ( P e 'c o 2 ) was measured 
throughout the operation using an infrared analyzer (Datex Capnomac Ultima, 
Instrumentation Corporation, Helsinki, Finland). The coefficient of variation 
for P e ’c o 2  measurement of values within the normal range is 0.2%. Minute 
ventilation was adjusted to obtain a P e ’c o 2 within the range 4.0 to 6.0 kPa. 
When Pe!co2 was stable, and just before commencing surgery, baseline 
recordings were made of minute ventilation, peak airway pressure, P e ’c o 2> a n d  
inspired oxygen concentration (Fi02). At the same time, an arterial blood 
sample was taken and analysed for oxygen tension (P<o2X carbon dioxide 
tension (Paco2)> hydrogen ion ([H+]), and bicarbonate concentration ([HCO3 ]). 
The coefficient of variation for Paco2 measurements of values within the 
normal range is 1.4%.
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In the laparoscopic group, pneumoperitoneum was achieved with CO2
I insufflation through a Veress needle to a maximum pressure of 15 mm Hg. No
j
patients developed surgical emphysema due to a misplaced Veress needle.
The operation was performed with the patient either horizontal or with a slight 
reverse Trendelenburg tilt. During surgery, ventilation settings in both groups 
were adjusted according to changes in P e 'c o 2 (arterial blood gas results were 
not available to the anaesthetist). At the time of removal of the gallbladder, all 
measurements were repeated along with arterial blood gas sampling.
Statistics
Measures between groups were compared with the unpaired t test, and within 
group changes, with the paired t test. The 95% confidence intervals (95% Cl) 
of the range of {P&coi - P^coi) values were calculated to assess the accuracy 
of capnography in monitoring P&co2 changes 304
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5.3 RESULTS
The groups were well matched for pre-operative patient characteristics 
(Table 5.1). The results are summarised in Tables 5.2 and 5.3.
Baseline results
On baseline measurements, both groups were well matched for ventilatory and 
blood gas values. P e 'c o 2 was of low accuracy in predicting P a c o 2  (95% Cl of 
the range of (Paco2 - P^'coi) -0.61 to +1.93 kPa. In other words, 95% of 
patients had a Paco2 between 0.61 kPa lower, and 1.93 kPa higher than the 
P vco i-  Figure 5.1).
Measurements at time o f  gallbladder removal
The mean time between beginning of surgery and the second set of
measurements was 40 minutes (range 20-95) in the open cholecystectomy
group, compared to 61 (30-115) in the laparoscopic cholecystectomy group
(t=4.1, p<0.001). All patients remained haemodynamically stable throughout
surgery.
In the minilaparotomy cholecystectomy group, no clinically significant 
changes occurred in ventilatory or arterial blood gas values (Table 5.2).
In the laparoscopic group, induction of a CO2 pneumoperitoneum resulted in a 
progressive rise in P^coi in the majority of patients. Despite a significant 
increase in minute ventilation, P&coi and arterial [H+] both increased 
significantly. There was no correlation between the duration of 
pneumoperitoneum and the rise in either minute ventilation (Pearson linear 
regression analysis r=0.27, p=0.15) or Paco2 (r=0.25, p=0.18). The 
pneumoperitoneum was also associated with a mean rise of 6  cm H2O in peak 
airway pressure. There were no significant changes in (Paco2 - P&C02X P&02 
or Ft02.
M inilaparotom y
group
(n=30)
L aparoscopic
group
(n=30)
Mean Age (range) 51 (19-82) 54 (31-80)
Male:Female Sex ratio 5:1 6.5:1
Height (mean/S.D.) 160(8) 161 (6)
Weight (mean/S.D.) 65 (10.0) 69(11)
FVC (litres - mean/S.D.) 2.87 (0.64) 2.94 (0.84)
FEV1 (litres - mean/S.D.) 2.32 (0.61) 2.39 (0.77)
PEFR (ml/sec - mean/S.D.) 370(112) 369 (128)
Asthma 3 4
Chronic Bronchitis 1 1
TABLE 5.1 Pre-operative patient characteristics, and pulmonary 
function in the two groups.
Open
group
(n=30)
Laparoscopic
group
(n=30)
t  test 
t  p value
Beginning of surgery
Minute Ventilation (1) 5.4 (1.2) 5.7 (1.4) 0 .8 0.44
P e’C0 2  (kPa) 4.6 (0.5) 4.6 (0.6) 0.2 0.81
PaC0 2 5.2 (0.7) 5.3 (0.9) 0 .6 0.57
Arterial [H+] (nM) 40(4) 41 (6) 0.9 0.38
(^aC0 2 -^E'C0 2 )(kPa) 0.6 (0 .6) 0.7 (0.7) 0.9 0.38
Pa()2 (kPa) 22.7 (7.6) 19.1 (7.1) 1.9 0.063
Fi02(% ) 38 (10) 38 (7) 0 .0 0.98
Peak Air Pressure (cm H2O) 17(4) 17(4) 0.3 0.79
[HC03 ] (mM) 25(2) 25 (2) 0.2 0 .86
At rem oval o f Gallbladder
Minute Ventilation (1) 5.1 (1.1) 6.1 (1.2) 3.4 p<0.001
PE'C02 (kPa) 4.8 (0.4) 5.4 (0.7) 3.9 p<0.001
PaC 02 (kPa) 5.5 (0.7) 6.0 (0.9) 2 .0 0.046
Arterial [H+] (nM) 42(5) 46(5) 2.9 0.006
(PaC02 - E'C02) (kPa) 0.8 (0.5) 0.6 (0.5) 0 .0 0.36
P a02  (kPa) 19.6 (4.7) 19.1 (5.7) 0.3 0.76
F i0 2  (%) 37 (7) 39 (6) -0.9 0.37
Peak Air Pressure (cm H2O) 18(4) 23(4) 5.3 p<0.001
[HC03] (mM) 24(2) 24(2) 0.4 0.64
TABLE 5.2 Ventilation and blood gas measurements at the
beginning of surgery, and at the time of removal of 
the gallbladder.
Open Laparoscopic
group group
t p value t p value
Minute Ventilation 1.4 0.16 2.0 0.0491
1.0 0.31 6.5 <0.001
PaC 02 2.4 0.021 4.5 <0.001
Arterial [H+] 3.3 0.002 6.5 <0.001
(P&C02 - P E'C02) 1.8 0.069 0.9 0.35
P&02 1.7 0.10 0.7 <0.51
F i02  (%) 1.2 0.22 0.4 0.68
Peak Air Pressure 2.3 0.025 11.4 <0.001
TABLE 5.3 Statistical comparison (paired t test) within-patients 
of ventilatory and blood gas changes (readings at 
baseline compared with those at gall bladder 
removal).
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As in baseline measurements, P^coi at the time of gallbladder removal was of 
low accuracy in predicting Paco2 (95% Cl of the range of (Paco2 - P^'coi) 
-0.4 to +1.6 kPa in both groups). Furthermore, there was poor concordance 
between the arterial to end-tidal P c 0 2  difference at the two time-points (95% 
Cl of agreement between baseline and second measurement: minilaparotomy 
cholecystectomy group -0.8 to +1.21 kPa, and laparoscopic group -1.5 to +1.3 
kPa).
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5.4 DISCUSSION
Our findings accord with the three reported studies of blood gas changes 
during laparoscopic cholecystectomy using a carbon dioxide 
pneumoperitoneum 13,14,305. wittgen et al compared the changes in 20 
normal patients to that in 10 patients with cardiorespiratory disease 13.
During laparoscopic cholecystectomy, Paco2 rose by 0.8kPa in the normal 
patients (without increasing ventilation), while in patients with 
cardiopulmonary disease Paco2 rose by 2.0 kPa despite an increase in minute 
ventilation of 1.2 litres. The corresponding changes in P e ' c o 2 were much less 
and did not fully reflect the changes in Paco2- in normal patients P e ' c o 2 
increased by only 0.3 kPa, while in the patients with cardiorespiratory disease, 
it increased by only 0.6 kPa. In contrast, in our study, and in a study of 
gynaecological laparoscopy 252 mean (Paco2 - Pe'co2) did not change 
significantly with CO2 pneumoperitoneum. Nevertheless, our findings of poor 
concordance between baseline (Paco2 - Pe'c02) and (Paco2 - Pz'coi) at the 
end of the procedure would support the conclusion of Wittgen et al that end- 
tidal measurement of Pco2 was a poor indicator of changes in Paco2 13. 
Marked within-patient variability in (Paco2 - Pe'C02) during anaesthesia has 
also been shown in a study of patients undergoing major surgery 255. Indeed, 
within-patient variations in (Paco2 - P^'coi) were comparable with or greater 
than the inter-patient differences.
In the other study of blood gas and ventilatory changes during laparoscopic 
cholecystectomy, Liu et a l 14 found that P e 'c o 2  and Paco2 both increased by 
a mean of 1.4 kPa during laparoscopic cholecystectomy, with 13 out of 16 
patients requiring an increase in minute ventilation to maintain PEc02 below 
6 kPa. In contrast to our findings, they claimed that there was good 
agreement between paired Pbcoi and Paco2 measurements, but their data do 
not support this statement. On analysing their results, it can be calculated that
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95% of patients had a P&coi between 0.42 kPa lower to 1.08 kPa higher than 
paired P&coi measurements.
In a pig model of laparoscopic cholecystectomy, Paco2 increased by 1.9 kPa 
and carbon dioxide output by 30% of baseline values 12 In a canine model 
of prolonged laparoscopy (2 hours), the effects of CO2 and helium 
pneumoperitoneum were compared 256. Even with a 57% increase in minute 
ventilation to maintain a constant P&c02, CO2 pneumoperitonum was 
associated with a significant rise in Faco2 and(Paco2 - P&c02)- The rise in 
minute ventilation requirement, Paco2> and (Pac02 - P^c02) was greater in 
dogs with papain-induced pulmonary emphysema, supporting the previously 
mentioned findings of Wittgen et al in patients with pulmonary disease 
undergoing laparoscopic cholecystectomy 13. Intra-operative blood gas 
monitoring may be advisable in patients with severe respiratory disease, as 
they may have larger differences between P& co2 and /* e 'cc> 2  and a greater 
tendency to retain CO2 13.
During laparoscopic procedures, changes in ventilation and perfusion 
distribution might be expected to occur because of the raised intrabdominal 
pressure. However, in this study (Paco2 - P&coi) or P&02 during the 
pneumoperitoneum were not significantly different from values pre­
insufflation or values in the open surgery group. In the present study, it was 
not possible to calculate the alveolar-arterial oxygen gradient {PAoi-Paoi) 
from the standard formula: PA02 = (FI02 x P b )  - Paco2/R, because absorption 
of carbon dioxide from the peritoneum would have resulted in changes in the 
respiratory quotient. Collection of exhaled gases would have been necessary 
to calculate the new respiratory quotient.
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In conclusion, laparoscopic cholecystectomy using a CO2 pneumoperitoneum 
is associated with a significant increase in carbon dioxide output, requiring a 
significant but variable increase in minute ventilation to prevent hypercarbia. 
P e ' c o 2 is of low accuracy in predicting P a c o 2 -  I t  is therefore suggesed that in 
patients undergoing laparoscopic cholecystectomy with a carbon dioxide 
pneumoperitoneum, ventilation be increased to maintain P e ' c o 2 towards the 
lower end of the normal range (4-5 kPa).
Chapter 6
HELIUM PNEUMOPERITONEUM FOR 
LAPAROSCOPIC CHOLECYSTECTOMY: 
VENTILATORY AND BLOOD GAS CHANGES
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6.1 INTRODUCTION
Carbon dioxide (CO2) is the gas most widely used for laparoscopic 
procedures. In Chapter 5, it was shown that CO2 is absorbed from the 
pneumoperitoneum into the blood stream, and in order to avoid significant 
respiratory acidosis during laparoscopic cholecystectomy, a substantial 
increase in the minute ventilation is required 12-14 in patients with severe 
cardiac or respiratory disease, it may be impossible to eliminate the increased 
CO2 burden by hyperventilation 13>15, and the ensuing hypercarbia and 
acidosis, which can result in cardiac arrhythmias 306, may necessitate the 
procedure being converted to an open surgical operation. This has prompted 
a search for an alternative to carbon dioxide for insufflation of the abdomen in 
this subgroup of patients.
Helium is an inert gas, which is chemically, physiologically and 
pharmacologically inert, and does not support combustion. Its physical 
property of low airflow resistance is utilized in patients with narrowed 
airways 265, and also to operate intra-aortic balloon pumps. It is thus readily 
available in hospitals. Two animal model studies have confirmed the 
suitability of helium for insufflating the abdomen during laparoscopy, and 
showed that it does not alter ventilation requirements 256,266  ^but there has 
been only one report of its use in humans for laparoscopy, in a study with ten 
patients 305.
The aim of this study, therefore, was to compare the effects of helium and 
carbon dioxide pneumoperitoneum on ventilatory and arterial blood gas 
changes during laparoscopic cholecystectomy.
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6.2 PATIENTS AND METHODS
This study was approved by the local hospital ethics committees. Informed 
consent was obtained from all patients in this study. In this study, ventilatory 
and blood gas changes were assessed in thirty consecutive patients who 
underwent laparoscopic cholecystectomy using a helium pneumoperitoneum 
(helium group). The methods were as described in the study in Chapter 5.
The thirty patients who underwent laparoscopic cholecystectomy using a 
CO2 pneumoperitoneum in Chaper 5 were used as a non-randomised 
historical control group (CO2 group).
Ventilatory and blood gas measurements were made after stabilization of 
anaesthesia and ventilation, but before commencing surgery. 
Pneumoperitoneum was achieved with either CO2 or helium insufflation to a 
maximum intraperitoneal pressure of 15 mm Hg. This was performed with 
either a Storz electronic Laparoflator model 264300 20 (Karl Storz GMBH 
and Co., Tuttlingen, Germany) or a Olympus Surgical Insufflator (KeyMed, 
Southend-on-Sea, Essex, UK). The Helium cylinders (British Oxygen 
Company, Guilford, Surrey, UK) filled at 135 barr were connected to the 
insufflator via an external valve which reduced the pressure to 10 barr. The 
operation was performed with the patient either horizontal or with a slight 
reverse Trendelenburg tilt. During surgery, ventilation settings in both groups 
were adjusted according to changes in Pe'c o 2 (arterial blood gas results were 
not available to the anaesthetist). At the time of removal of the gallbladder, all 
measurements were repeated along with arterial blood gas sampling.
The alveolar-arterial oxygen gradient (PAo2-^>ao2) was calculated using the 
formula for calculating alveolar oxygen partial pressure 307:
P A 02 = (H02 x Pb) - Paco2/R
107
where Pb = barometric pressure minus water vapour pressure saturated at 
body temperature, R = respiratory quotient estimated at 0.8. Because the 
calculation of (PAo2~Pa02) was dependent on a estimate of the respiratory 
quotient, (PA02-P&02) could only be calculated for the helium insufflation 
group, because CO2 absorption from the peritoneum in the CO2 insufflation 
would have altered the respiratory quotient.
Statistics
Measures between groups were compared with the unpaired t test, and within 
group changes, with the paired t test.
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6.3 RESULTS
There were no significant differences between the two groups in pre-operative 
patient characteristics (Table 6 .1). The results are summarised in Table 6.2 and 
Table 6.3.
Baseline results
On baseline measurements, both groups were well matched for ventilatory and 
blood gas values.
The mean (SD) time between beginning of surgery and the second set of 
measurements was 61 minutes (21) in the helium group, and 61 (20) in the 
carbon dioxide group. All patients remained haemodynamically stable 
throughout surgery.
In the helium group, minute ventilation was reduced slightly, but no 
significant changes occurred in P&coi or P e 'c o 2  values (Table 6 . 2 ) .  However, 
peak airway pressure rose by 7 cm H2O and there was a significant rise in both 
(Paco2 - Pscoi) and (PAoi-Pzoi)-
In the CO2 group, despite a significant increase in minute ventilation, Paco2 
and arterial [H+] both increased significantly. The pneumoperitoneum was 
also associated with a mean rise of 6  cm H2O in peak airway pressure. There 
were no significant changes in (Paco2 - P&C02), P&02 or F1O2.
Four patients in the helium group, in whom gas was accidentally insufflated 
into the abdominal wall, had surgical emphysema in the anterior abdominal 
wall, which remained for three to five days. This was not associated with any 
discomfort, and did not impede patient recovery.
Helium
group
(n=30)
Carbon Dioxide 
group 
(n=30)
Mean Age (range) 49 (24-73) 54 (31-80)
No. of females (%) 28 (93%) 26 (87%)
Height (mean/S.D.) 160(8) 161 (6)
Weight (mean/S.D.) 74(24) 69(11)
Asthma 1 4
Chronic Bronchitis 4 1
TABLE 6 . 1  Pre-operative patient characteristics in the 
groups.
Helium
group
(n=30)
Carbon Dioxide t test: 
group
(n=30) t  p value
Beginning of surgery
Minute Ventilation (1) 5.8 (1.2) 5.7 (1.4) 0.5, 0.63
P e’C0 2  (kPa) 4.5 (0.6) 4.6 (0.6) -0.4 0.72
PaC0 2 5.2 (0.7) 5.3 (0.9) -0.4 0.67
Arterial [H+] (nM) 38(3) 41 (6) -2.1 0.037
(^aC02 - PE'C02) (kPa) 0.7 (0.4) 0.7 (0.7) -0.2 0.81
P a02  (kPa) 21.4 (6.9) 19.1 (7.1) 1.2 0 .22
Fi02(% ) 40(6) 38 (7) 1.2 0.23
(FA02-Fa02) (kPa) 10.3 (7.3) 10.6 (6 .1) 0.1 0 .88
Peak Air Pressure (cm H2O) 18(5) 17(4) 0.2 0.87
[HC03 ] (mM) 26(2) 25(2) 1.8 0.077
At rem oval o f G allbladder
Minute Ventilation (1) 5.5 (1.2) 6.1 (1.2) 3.4 <0.001
PE'C02 (kPa) 4.5 (0.6) 5.4 (0.7) 3.9 <0.001
PaC 02 (kPa) 5.3 (0.6) 6.0 (0.9) 2 .0 0.046
Arterial [H+] (nM) 40(3) 46(5) 2.9 0.006
(PaC02 - P  E'C02) (kPa) 0.9 (0.6) 0.6 (0.5) 1.7 0.096
Pa02  (kPa) 17.9 (5.0) 19.2 (5.7) 0.3 0.76
F i02  (%) 40(7) 39 (6) -0.9 0.37
(PA02-Pa02) (kPa) 13.5 (8 .8) - - -
Peak Air Pressure (cm H2O) 25(7) 23(4) 5.3 <0.001
[HC03 ] (mM) 25(2) 24(2) 0.4 0.64
TABLE 6.2 Ventilation and blood gas measurements at the
beginning of surgery, and at the time of removal of 
the gallbladder.
Helium group Carbon dioxide group
t p value t p value
Minute Ventilation 2.2 0.036 2.0 0.0491
P e'C02 0.8 0.43 6.5 <0.001
FaC 02 -0.6 0.52 4.5 <0.001
Arterial [H+] -3.3 0.003 6.5 <0.001
(PaC02 - PE'C02) -2.1 0.047 0.9 0.35
P a02 3.3 0.003 0.7 0.51
F i02  (%) 0.3 0.74 0.4 0.68
(PA 02-Pa02) (kPa) -2.9 0.006 - -
Peak Air Pressure -12.8 <0.001 11.4 <0.001
[HC03] (mM) 4.9 <0.001 2.5 0.019
TABLE 6.3 Statistical comparison (paired t test) within-patients 
of ventilatory and blood gas changes (readings at 
baseline compared with those at gall bladder 
removal).
109
6.4 DISCUSSION
This study has shown that helium can be effectively used for laparoscopy and 
avoids the problem of carbon dioxide absorption.
The only drawback in using helium for laparoscopy is that it is not very water- 
soluble. Hence, in four patients in this study where the gas was accidentally 
insufflated into the abdominal wall, surgical emphysema was present for three 
to five days after operation. Secondly, it is likely that it has a lower safety 
margin than CO2 in the very rare event of gas embolism 308. In order to 
reduce the risk of gas embolism when using a helium pneumoperitoneum, the 
open technique of laparoscopy might be used 15 *, which avoids the risk of 
insufflation into a blood vessel through a misplaced Veress needle.
Helium pneumoperitoneum resulted in a increase in both (Paco2 - P & C 0 2 ) and 
(PPi02-Pzo2)- The likely mechanism of this effect is that splinting of the 
diaphragm by the increased intra-abdominal pressure might have resulted in 
collapse of basal airways, which together with the increased ventilation 
pressure requirement might have altered the ventilation and perfusion 
distribution, resulting in increased right to left shunt, and an increased dead 
space. An animal model study also demonstrated that pneumoperitoneum 
with either CC>2 or helium resulted in an increase in {PA02-P&02), the effect 
being more marked in animals with papain-induced emphysema 236.
In conclusion, this study has shown that laparoscopy with helium peritoneal 
insufflation does not result in significant changes in ventilation requirements. 
However, the theoretical risks resulting from its low water-solubility preclude 
its routine use for most patients. Nevertheless, it may be a suitable alternative 
for patients with severe cardiorespiratory disease undergoing laparoscopic 
procedures in whom carbon dioxide insufflation results in excessive
hypercarbia and acidosis. Animal model studies are required to compare the 
effects of gas embolism with helium to that of carbon dioxide to clarify 
whether helium is associated with a higher theoretical risk in the rare event of 
accidental insufflation into a blood vessel.
CONCLUSIONS
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Although laparoscopic cholecystectomy was first performed only five years 
ago, it has been introduced into routine practice in most western countries, 
and has become the treatment of choice for symptomatic cholelithiasis. Its 
rapid introduction occurred without rigorous scientific evaluation comparing 
it with the gold standard, open cholecystectomy. The randomised trial 
described in this thesis has confirmed that laparoscopic cholecystectomy has 
significant advantages over open cholecystectomy, even when the latter is 
performed through a minilaparatomy incision. The advantages compared with 
minilaparotomy cholecystectomy are:
1) Reduced postoperative pain, with a significant reduction for up to at 
least a week after surgery.
2) Reduced requirements for opiate analgesics in the postoperative period.
3) Less reduction in postoperative pulmonary function and therefore better 
oxygen saturation.
4) Post-operative hospital stay is halved from a median of four days to two 
days.
5) The time to return to normal activity in the home is reduced from fifteen 
days to ten days.
6 ) General health survey measures such as physical and social functioning, 
role limitation due to physical problems and depression scores are all 
significantly better in the week following surgery. Even a month after 
surgery, laparoscopic patients have better physical functioning and 
better depression scores.
The randomised trial described in this thesis found that the laparoscopic 
cholecystectomy was nearly £400 more expensive than minilaparotomy 
cholecystectomy. However, this difference could be reduced to less than 
£100 if re-usable instruments are used in preference to disposables. It is likely
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that as surgeons complete the learning curve, operation times are likely to 
become shorter. As surgeons becomme more confident in early hospital 
discharge, average hospital stay in this country may be reduced further to 
approach the average one day stay reported in many centres in America. 
These two factors should reduce the costs of laparosocopic cholecystectomy 
to a figure comparable to or less than minilaparotomy cholecystectomy.
A randomised trial of three hundred patients cannot make much comment on 
the relative incidence of complications of cholecystectomy. Large scale audit 
studies have shown that laparoscopic cholecystectomy has been associated 
with a higher incidence of bile duct injuries, bile leaks, and deaths due to 
technical complications. However, there is evidence to suggest that this may 
be due in part to the learning curve. Rigorous large-scale audit is needed to 
ensure that the apparent superiority of laparoscopic cholecystectomy is 
maintained in the long term.
With the increasing experience of surgeons with the technique of 
laparoscopic cholecystectomy, many of the absolute contraindications of the 
technique have become relative. Most patients with acute cholecystitis or 
previous upper abdominal surgery can now safely undergo cholecystectomy 
by the laparoscopic approach. However, there will always be a proportion of 
patients with symptomatic cholelithiasis in whom the technique cannot be 
performed. In some of these patients, minilaparotomy may be a reasonable 
alternative. This study has shown that minilaparotomy cholecystectomy 
results in a median hospital stay of four days and return to work in the home 
in about two weeks, which is significantly shorter than that the usual 
recovery period expected after standard open cholecystectomy in the UK. 
The technique is also a suitable alternative for surgeons who feel unable to
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learn the laparoscopic technique or who do not have access to laparoscopic 
equipment.
The role of laparoscopic cholecystectomy in patients with evidence of 
common bile duct (CBD) stones remains to be clarified. At present most of 
these patients are managed by endoscopic sphincterotomy and stone 
clearance before proceeding to laparoscopic cholecystectomy. However, the 
incidence of complications from endoscopic sphincteotomy is independent of 
age. Thus patients at low risk from open surgery (aged under 60) who 
undergo laparoscopic cholecystectomy and endoscopic treatment of duct 
stones may suffer greater morbidity and mortality than they would if they 
underwent open operation. Further studies are required to clarify this area.
In Chapter 4, it was shown that both laparoscopic and minilaparotomy are 
associated with a significant metabolic response. The time course and 
magnitude of changes are similar for both procedures, but there is wide inter­
individual variation in the magnitude of the response. The similar metabolic 
response of the two procedures contrasts with the clinical benefits of less 
postoperative pain and more rapid recovery after the laparoscopic procedure. 
These findings suggest that factors other than the metabolic reponse are 
important in determining recovery following surgery.
The study in Chapter 5 has demonstrated that laparoscopic cholecystectomy 
using a CO2 pneumoperitoneum is associated with a significant increase in 
carbon dioxide output, requiring a significant but variable increase in minute 
ventilation to prevent hypercarbia. Capnography may underestimate the rises 
in arterial carbon dioxide levels, and it is therefore suggested that minute 
ventilation be increased to maintain end-tidal carbon dioxide levels towards 
the lower end of the normal range (4-5 kPa). The study in Chapter 6 has
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shown that helium is a suitable alternative to carbon dioxide for peritoneal 
insufflation, and that helium does not result in significant changes in 
ventilation requirements. However, the theoretical risks resulting from its low 
water-solubility, preclude its routine use for most patients. Nevertheless, it 
may be a suitable alternative for patients with severe cardiorespiratory disease 
undergoing laparoscopic procedures, in whom carbon dioxide insufflation 
results in excessive hypercarbia and acidosis. Animal model studies are 
required to compare the effects of air embolism with helium to that of carbon 
dioxide to clarify whether helium is associated with a higher theoretical risk in 
the rare event of accidental insufflation into a blood vessel.
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QUESTIONNAIRE ABOUT SURGEONS1 VIEWS ON 
RANDOMISED TRIALS COMPARING LAPAROSCOPIC 
AND OPEN CHOLECYSTECTOMY
ARE YOU A GENERAL SURGEON Yes I I No
(If NOT, do not complete questionnaire) ----
1 Do you work in: District General Hospital
Teaching Hospital (NHS appointm ent) 
Teaching Hospital (Academic appointm ent)
2 How many years have you been appointed as a consultant 
surgeon?
3 Approximately how many laparoscopic cholecystectomies 
have you performed?
Are you satisfied with the safety of laparoscopic Very satisfied 
cholecystectomy?
Satisfied 
Unsure 
Concerned 
Very concerned
5 Do you think there is a necessity for a Very necessary
randomised trial comparing standard
cholecystectomy with laparoscopic Probably necessary
cholecystectomy? TT; J Unsure
Probably not necessary
Totally unnecessary
6 Do you think there is a necessity for a Very necessary
randomised trial comparing minilaparotomy
cholecystectomy with laparoscopic Probably necessary
cholecystectomy? XTJ J Unsure
Probably not necessary
Totally unnecessary
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I
i
| 7 Is a randomised trial of standard
! cholecystectomy versus laparoscopic
cholecystectomy possible on a practical 
level (e.g. getting patient consent):
8 Is a randomised trial of standard 
cholecystectomy versus laparoscopic 
cholecystectomy ethical:
Unsure
Ethical
9 If you think that a randomised trial is unethical, Why?
Yes No Unsure□ □ □
Highly unethical 
A little unethical
10 Hypothetically, would you be interested Very interested
in participating in a randomised trial of
laparoscopic cholecystectomy? M oderately interested
Unsure 
Not interested
11 If you were admitted to a hospital not 
known to yourself for an elective 
cholecystectomy (albeit an unlikely 
scenario) and were offered laparoscopic or 
open cholecystectomy, which procedure 
would you choose:
Laparoscopic
cholecystectomy
Open
cholecystectomy
12 Any other comments:
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Questionnaire sent to patients one week after 
laparoscopic or minilaparotomy cholecystectomy
THE EFFECT OF YOUR RECENT OPERATION
I Have you returned to your job of work (that is, paid 
employment) since your operation?
(Please tick the bos which best applies to you)
If 'yes', how long after your operation did you return 
to work?
Yes No I have no 
paid jobp|□ d
days
Are you able to look after the home since your 
operation (for example, cleaning and cooking, repairs, 
odd jobs around the home, and so on)?
(Please tick the box which best applies to you)
If 'yes’, how long after your operation did you return 
to work?
Yes No
□
I do not 
look after 
the home
days
Are you able to enjoy your usual social life (for 
example, going out, seeing friends, going to the pub, 
etc) since your operation?
(Please tick the box which best applies to you)
If 'yes', how long after your operation were you able 
to enjoy your usual social life again?
Yes
□
No Not
applicable□
days
4 Are you able to enjoy your usual sex life since your 
operation?
(Please tick the box which best applies to you)
If 'yes', how long after your operation were you able 
to enjoy your usual sex life again?
Yes No Not
applicable□
days
Are you able to enjoy your usual interests and hobbies 
(for example, sports, watching television, arts and 
crafts, do it yourself, etc) since your operation? 
(Please tick the box which best applies to you)
Yes No Not
applicable□
If 'yes', how long after your operation were you able 
to return to your usual interests? days
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Do you think the outcome of the Excellent
operation itself has been: Good
(Please tick the box which best
describes you) Fair
Poor 
Very poor
7 How satisfied are you with the Very satisfied
appearance of your operation scars?
(Please tick the box which best M oderately satisfied
describes you Barely satisfied
M oderately dissatisfied 
Very dissatisfied
8 If someone else had the same gallbladder Yes No
problem as you, would you recommend I I
the operation you had? I---- 1 ----
(Please tick one box)
YOUR HEALTH SINCE YOUR OPERATION
The following questions ask for your views about your health and how 
you have felt about life in general since returning home after your 
operation. If you are unsure about how to answer any question, try and 
think about your health in general and give the best answer you can. Do 
not spend too much time over each answer as your immediate responses 
are likely to be the most helpful.
In general, would you say your health now is: Excellent
(Tick the box which best describes you)
Good
Fair
Poor
Very poor
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IQ How is your health now compared M uch better
with before your operation?
y°u) About the same
Somewhat worse 
M uch worse
11 The following questions are about activities you might do during a
typical day. Has your health limited you in these activities at any time 
since returning home? If so, how much?
(Tick one answer for each activity)
A lot A little About the Less
more limited more limited same as limited
than before than before before than before
i Vigorous activities, such 
as running, lifting heavy 
objects, participating in 
strenuous sports
□ □ □
ii Moderate activities, such as 
moving a table, pushing a 
vacuum cleaner, bowling 
or playing golf
□ □ □ □
iii Lifting or carrying 
groceries □ □ □
iv Climbing several flights of 
stairs
V Climbing one flight of 
stairs □ □ □ □
vi Bending, kneeling or 
stooping
vii Walking more than a mile □ □
viii Walking half a mile
ix Walking 100 yards □ □ □ □
X Bathing and dressing 
yourself
Appendix II (continued)
At any time since returning home, have you had any of the following 
problems with your work or other regular daily activities as a result of 
your operation?
(Tick one answer for each activity)
Yes
Cut down on the amount of time you spent on work 
or other activities □ No□
Accomplished less than you would like
Were limited in the kind of work or other activities □ □
Had difficulty performing the work or other 
activities (e.g. it took extra effort)
At any time since returning home, have you had any of the following 
problems with your work or other regular daily activities as a result of 
any emotional problems (such as feeling depressed or anxious)?
(Tick one answer for each activity)
Yes No
Cut down on the amount of time you spent on work I I
or other activities I------ 1 —
Accomplished less than you would like
Didn't do work or other activities as carefully as 
usual
At any time since returning home, have your Not a t all
physical or emotional problems interfered with your
normal social activities with family, friends,
neighbours or groups? M oderately
(Tick the box which best describes you) Quite a  bit
Extremely
What is the worst bodily pain you have had since 
returning home after your operation?
(Tick the box which best describes this pain)
M oderate 
Severe 
Very severe
None 
Very mild 
Mild
Appendix II (continued)
121
16 At any time since returning home, how much has 
pain interfered with your normal work (including 
work both outside the home and housework)? 
(Tick the box which best describes you)
Not at all 
A little bit 
Moderately 
Quite a bit 
Extremely
HOW YOU ARE FEELING IN GENERAL
17 I feel tense Most of the time
A lot of the time 
From time to time, occasionally
Not at all
18 I still enjoy the things I used to enjoy Definitely as much
Not quite so much 
Only a little 
Hardly at all
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me
Not at all
20 I can laugh and see the funny As much as I always could
side of things -T * .Not quite so much now
Definitely not so much now
Not at all
19 I get a sort of frightened
feeling as if something awful 
is about to happen
Appendix II (continued)
21 Worrying thoughts go through 
my mind
A great deal of the time 
A lot of the time 
From time to time but not too often 
Only occasionally
22 I feel cheerful Not at all 
Not often 
Sometimes 
Most of the time
23 I can sit at ease and feel relaxed Definitely 
Usually 
Not often 
Not at all
24 I feel as if I am slowed down Nearly all the time 
Very often 
Sometimes 
Not at all
25 I get a sort of frightened feeling like 
'butterflies' in the stomach
Not at all 
Occasionally 
Quite often 
Very often
26 I have lost interest in my Definitely
appearance j don't take as much care as I should
I may not take quite as much care 
I take just as much care as ever
Appendix II (continued)
27 I feel restless as if I have to be 
on the move
28 I look forward with enjoyment 
to things
29 I get sudden feelings of panic
30 I can enjoy a good book or radio 
or TV programme
Very much indeed 
Quite a lot 
Not very much 
Not at all
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all
Very often indeed 
Quite often 
Not very often 
Not at all
Often 
Sometimes 
Not often 
Very seldom
Thank you for completing this questionnaire
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